<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PRG2 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>PRG2</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/P13727" target="_blank" class="term-link">
                        P13727
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-draft">
                    DRAFT
                </span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Aliases:</span>
                <div class="aliases">
                    
                    <span class="badge">Eosinophil major basic protein 1</span>
                    
                    <span class="badge">MBP-1</span>
                    
                    <span class="badge">MBP</span>
                    
                    <span class="badge">BMPG</span>
                    
                    <span class="badge">Bone marrow proteoglycan</span>
                    
                    <span class="badge">Pregnancy-associated major basic protein</span>
                    
                </div>
            </div>
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "PRG2";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="P13727" data-a="DESCRIPTION: Eosinophil major basic protein 1 (MBP-1), a highly..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>Eosinophil major basic protein 1 (MBP-1), a highly cationic protein (~13.8 kDa, pI ~11.4) that is the predominant constituent of the crystalline core in eosinophil secondary granules. Synthesized as a 222-amino acid precursor with an acidic, heavily glycosylated prosegment (~9 kDa) that neutralizes the toxicity of the basic mature domain during biosynthesis. The prosegment contains N-linked, O-linked, and glycosaminoglycan chains (hence &#34;proteoglycan 2&#34;), raising precursor mass to 30-50 kDa. Upon maturation, the prosegment is proteolytically cleaved in the Golgi/secretory granule, yielding the active 117-residue MBP that is stored in paracrystalline arrays within granules. Structurally, MBP adopts a C-type lectin-like fold but lacks Ca2+-binding sites; instead presents a highly cationic surface for binding sulfated polysaccharides like heparin and heparan sulfate. Primary function: cytotoxic effector in antiparasitic defense - directly damages helminth larvae membranes and cuticles (experimental knockout mice show impaired killing of Strongyloides and filarial worms). Also exhibits broad antimicrobial activity against bacteria and fungi via membrane disruption. Immunomodulatory roles: triggers degranulation of mast cells and basophils (histamine release), activates neutrophils (superoxide production) and platelets. Toxic to host cells - causes epithelial damage and denudation in allergic diseases. In asthma, acts as allosteric antagonist of M2 muscarinic acetylcholine receptors on parasympathetic neurons, disabling inhibitory feedback and causing bronchospasm and airway hyperresponsiveness. Inhibits heparanase (first known endogenous heparanase inhibitor). In chronic settings, induces TGF-Œ≤ and MMP-1 expression, promoting fibrosis and tissue remodeling. Dual biology: the proMBP form is abundantly expressed in placenta during pregnancy and secreted into maternal circulation, where it forms disulfide-linked 1:1 complexes with PAPP-A (pregnancy-associated plasma protein A), inhibiting this metalloprotease&#39;s cleavage of IGFBPs and thereby modulating IGF signaling for fetal growth. ProMBP also binds angiotensinogen and complement C3dg. The PAPP-A/proMBP complex is a clinical biomarker in first-trimester Down syndrome screening. ProMBP is non-toxic (acidic prosegment renders it inert), contrasting with the highly cytotoxic mature MBP released from eosinophils. MBP levels correlate with disease severity in asthma, eosinophilic esophagitis, and other eosinophil-driven conditions.</p>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Proposed New Ontology Terms</h2>
        
        <div class="proposed-term">
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>cytotoxic effector activity</h3>
                <span class="vote-buttons" data-g="P13727" data-a="cytotoxic effector activity" data-r="" data-act="NEW">
                    <button class="vote-btn" data-v="up" title="Agree this term should be created">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with creating this term">üëé</button>
                </span>
            </div>

            
            <p><strong>Definition:</strong> The activity of directly killing or damaging target cells or organisms through membrane permeabilization or disruption, particularly via cationic charge-based interactions, as exhibited by antimicrobial peptides and granule proteins.</p>
            

            
            <p><strong>Justification:</strong> MBP&#39;s primary function is direct killing of parasites and microbes via membrane permeabilization. Current GO lacks specific term for this cationic antimicrobial peptide-like activity. Knockout mice show impaired parasite killing; purified MBP kills helminths, bacteria, fungi, and mammalian cells via membrane disruption.</p>
            

            
            <p><strong>Parent term:</strong>
                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003674" target="_blank" class="term-link">
                    molecular_function
                </a>
            </p>
            

            

            
        </div>
        
        <div class="proposed-term">
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>M2 muscarinic acetylcholine receptor antagonist activity</h3>
                <span class="vote-buttons" data-g="P13727" data-a="M2 muscarinic acetylcholine receptor antagonist activity" data-r="" data-act="NEW">
                    <button class="vote-btn" data-v="up" title="Agree this term should be created">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with creating this term">üëé</button>
                </span>
            </div>

            
            <p><strong>Definition:</strong> The activity of binding to M2 muscarinic acetylcholine receptors and blocking their inhibitory function, thereby preventing feedback inhibition of acetylcholine release from parasympathetic neurons.</p>
            

            
            <p><strong>Justification:</strong> MBP&#39;s allosteric antagonism of M2 receptors on airway nerves is a key mechanism in asthma pathophysiology, but lacks specific GO annotation. MBP binds M2 receptors, blocks inhibitory feedback, causes unrestrained acetylcholine release and bronchospasm. Heparin neutralization of MBP prevents this effect.</p>
            

            
            <p><strong>Parent term:</strong>
                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030594" target="_blank" class="term-link">
                    neurotransmitter receptor activity
                </a>
            </p>
            

            

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002376" target="_blank" class="term-link">
                                    GO:0002376
                                </a>
                            </span>
                            <span class="term-label">immune system process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0002376" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Electronic annotation for immune system process from UniProt keywords. MBP is central to eosinophil-mediated immunity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological process - MBP is key effector in antiparasitic and antimicrobial defense.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0005576" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular region from UniProt subcellular location. MBP is released from eosinophils and acts extracellularly.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization - MBP functions in extracellular space after degranulation.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006955" target="_blank" class="term-link">
                                    GO:0006955
                                </a>
                            </span>
                            <span class="term-label">immune response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0006955" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Electronic annotation for immune response from InterPro domain. MBP kills parasites and microbes as part of innate immunity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function in immune defense, experimentally validated in helminth killing.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008201" target="_blank" class="term-link">
                                    GO:0008201
                                </a>
                            </span>
                            <span class="term-label">heparin binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0008201" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Heparin binding from UniProt keywords. MBP strongly binds heparin and heparan sulfate via cationic surface.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core molecular function - crystal structure shows heparin-binding site, physiologically relevant for tissue interactions.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030133" target="_blank" class="term-link">
                                    GO:0030133
                                </a>
                            </span>
                            <span class="term-label">transport vesicle</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0030133" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Transport vesicle from UniProt subcellular location. MBP is in secretory granules.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Accurate - MBP is stored in eosinophil secondary granules (transport/secretory vesicles).
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030246" target="_blank" class="term-link">
                                    GO:0030246
                                </a>
                            </span>
                            <span class="term-label">carbohydrate binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0030246" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Carbohydrate binding from UniProt keywords. MBP has C-type lectin-like fold and binds sulfated polysaccharides.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Structural feature - lectin-like fold binds sulfated carbohydrates.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031410" target="_blank" class="term-link">
                                    GO:0031410
                                </a>
                            </span>
                            <span class="term-label">cytoplasmic vesicle</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0031410" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cytoplasmic vesicle from UniProt keywords. Same as transport vesicle - eosinophil granules.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Granules are cytoplasmic vesicles, accurate localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042742" target="_blank" class="term-link">
                                    GO:0042742
                                </a>
                            </span>
                            <span class="term-label">defense response to bacterium</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0042742" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Defense response to bacterium from UniProt keywords. MBP has direct antimicrobial activity against Gram+ and Gram- bacteria.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Experimentally supported - MBP and derived peptides kill bacteria via membrane disruption.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/12421832" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:12421832
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Complex of pregnancy-associated plasma protein-A and the pro...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0005515" data-r="PMID:12421832" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein binding from PMID:7685339 (original PAPP-A/proMBP complex discovery).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Seminal paper demonstrating proMBP-PAPP-A disulfide bridge in pregnancy serum.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/7685339" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:7685339
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Circulating human pregnancy-associated plasma protein-A is d...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0005515" data-r="PMID:7685339" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein binding from PMID:7685339 (original PAPP-A/proMBP complex discovery).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Seminal paper demonstrating proMBP-PAPP-A disulfide bridge in pregnancy serum.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002215" target="_blank" class="term-link">
                                    GO:0002215
                                </a>
                            </span>
                            <span class="term-label">defense response to nematode</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0002215" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Defense response to nematode from Ensembl orthology. MBP is critical for killing helminth parasites.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core antiparasitic function - knockout mice show impaired killing of Strongyloides and filarial worms.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032693" target="_blank" class="term-link">
                                    GO:0032693
                                </a>
                            </span>
                            <span class="term-label">negative regulation of interleukin-10 production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0032693" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Negative regulation of IL-10 production from Ensembl orthology. May reflect immunomodulatory effects.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Pleiotropic immunomodulation, not direct core function of MBP.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032753" target="_blank" class="term-link">
                                    GO:0032753
                                </a>
                            </span>
                            <span class="term-label">positive regulation of interleukin-4 production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0032753" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Positive regulation of IL-4 production from Ensembl orthology. Reflects role in Th2 allergic responses.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Downstream effect in allergic inflammation, not core molecular function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030021" target="_blank" class="term-link">
                                    GO:0030021
                                </a>
                            </span>
                            <span class="term-label">extracellular matrix structural constituent conferring compression resistance</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/28344315" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:28344315
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Proteomic characterization of human multiple myeloma bone ma...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0030021" data-r="PMID:28344315" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ECM structural constituent conferring compression resistance from PMID:28344315 (myeloma bone marrow ECM proteomics).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Over-annotation from high-throughput proteomics. MBP is not a structural ECM protein, likely contaminant from eosinophils in marrow.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031012" target="_blank" class="term-link">
                                    GO:0031012
                                </a>
                            </span>
                            <span class="term-label">extracellular matrix</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/28344315" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:28344315
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Proteomic characterization of human multiple myeloma bone ma...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0031012" data-r="PMID:28344315" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular matrix from PMID:25037231 (proteomics).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same as above - not an ECM component.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030021" target="_blank" class="term-link">
                                    GO:0030021
                                </a>
                            </span>
                            <span class="term-label">extracellular matrix structural constituent conferring compression resistance</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">RCA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25037231" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25037231
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Extracellular matrix signatures of human primary metastatic ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0030021" data-r="PMID:25037231" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ECM structural constituent from PMID:25037231 (colon cancer ECM proteomics). Same as above.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Over-annotation from proteomics. MBP may bind to ECM via heparan sulfate but is not a structural ECM component.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031012" target="_blank" class="term-link">
                                    GO:0031012
                                </a>
                            </span>
                            <span class="term-label">extracellular matrix</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25037231" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25037231
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Extracellular matrix signatures of human primary metastatic ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0031012" data-r="PMID:25037231" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular matrix from PMID:25037231 (proteomics).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same as above - not an ECM component.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6800434
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0005576" data-r="Reactome:R-HSA-6800434" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular region from PMID:8547309 (rat MBP cloning, showing secreted protein).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Confirmed secreted protein localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1904813" target="_blank" class="term-link">
                                    GO:1904813
                                </a>
                            </span>
                            <span class="term-label">ficolin-1-rich granule lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6800434
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:1904813" data-r="Reactome:R-HSA-6800434" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Ficolin-1-rich granule lumen from Reactome:R-HSA-6800434. Very specific granule type.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Too specific. MBP is in eosinophil granules, not ficolin-rich granules (neutrophil-specific). Likely annotation error.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23533145
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    In-depth proteomic analyses of exosomes isolated from expres...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0070062" data-r="PMID:23533145" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular exosome from PMID:23533145 (prostatic secretion exosome proteomics).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Over-annotation from high-throughput study. MBP not normally in exosomes, likely contamination.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030246" target="_blank" class="term-link">
                                    GO:0030246
                                </a>
                            </span>
                            <span class="term-label">carbohydrate binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/1565101" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:1565101
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Purification and cDNA cloning of a novel factor produced by ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0030246" data-r="PMID:1565101" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Carbohydrate binding with traceable author statement from PMID:1565101 (original characterization).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Experimentally demonstrated carbohydrate binding activity.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/8547309" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:8547309
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning of cDNA for rat eosinophil major basic protein.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P13727" data-a="GO:0005576" data-r="PMID:8547309" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular region from PMID:8547309 (rat MBP cloning, showing secreted protein).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Confirmed secreted protein localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Binding sulfated polysaccharides (heparin, heparan sulfate) via highly cationic surface on C-type lectin-like fold. This interaction is central to MBP&#39;s biological activities - enables binding to pathogen surfaces, host cell membranes, and tissue matrix components.</h3>
                <span class="vote-buttons" data-g="P13727" data-a="FUNCTION: Binding sulfated polysaccharides (heparin, heparan..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008201" target="_blank" class="term-link">
                            heparin binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002215" target="_blank" class="term-link">
                                defense response to nematode
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042742" target="_blank" class="term-link">
                                defense response to bacterium
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                extracellular region
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030133" target="_blank" class="term-link">
                                transport vesicle
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/PRG2/PRG2-uniprot.txt
                            
                        </span>
                        
                        <div class="finding-text">Crystal structure reveals heparin-binding site; MBP damages helminth and bacterial membranes via cationic interactions.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12421832" target="_blank" class="term-link">
                            PMID:12421832
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/1565101" target="_blank" class="term-link">
                            PMID:1565101
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Purification and cDNA cloning of a novel factor produced by a human T-cell hybridoma: sequence homology with animal lectins.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link">
                            PMID:23533145
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25037231" target="_blank" class="term-link">
                            PMID:25037231
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28344315" target="_blank" class="term-link">
                            PMID:28344315
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/7685339" target="_blank" class="term-link">
                            PMID:7685339
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8547309" target="_blank" class="term-link">
                            PMID:8547309
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Cloning of cDNA for rat eosinophil major basic protein.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6800434
                        
                    </span>
                </div>
                
                <div class="reference-title">Exocytosis of ficolin-rich granule lumen proteins</div>
                
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(PRG2-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="P13727" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-03T21:51:35.628950'<br />
end_time: '2025-11-03T21:51:35.630758'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: P13727<br />
  gene_symbol: PRG2<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 81</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene PRG2 (P13727) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="gene-prg2-p13727-eosinophil-major-basic-protein-mbp-in-human">Gene PRG2 (P13727) ‚Äì Eosinophil Major Basic Protein (MBP) in Human</h1>
<h2 id="introduction-and-gene-overview">Introduction and Gene Overview</h2>
<p>The <strong>PRG2 gene</strong> (Proteoglycan 2) encodes <strong>eosinophil major basic protein 1 (MBP-1)</strong>, a highly cationic protein that is the predominant constituent of the crystalline core in eosinophil granules (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=Summary%20The%20protein%20encoded%20by,positive%20bacteria%2C%20Gram">www.ncbi.nlm.nih.gov</a>). MBP-1 is often simply called <strong>Major Basic Protein</strong> for its abundance and strong basicity; it is also known as <strong>bone marrow proteoglycan</strong> (BMPG) and was historically termed <strong>pregnancy-associated major basic protein</strong> due to its presence in the placenta (<a href="https://www.reactome.org/content/schema/instance/browser/uniprot%3AP13727#:~:text=,associated%20major%20basic%20protein%20%2Fcomponent">www.reactome.org</a>). The mature MBP-1 protein is relatively small (~13.8 kDa) and extremely basic (isoelectric point ‚âà11.4) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=Eosinophil%20Major%20Basic%20Protein">pmc.ncbi.nlm.nih.gov</a>). It is stored in eosinophils ‚Äì a type of white blood cell ‚Äì and released during immune responses. Broadly, MBP-1 serves dual roles as a <strong>toxic effector molecule in host defense</strong> (particularly against parasites) and as a mediator of <strong>inflammatory tissue damage</strong> in allergic conditions (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=complex%20with%20several%20other%20proteins,Alternatively">www.ncbi.nlm.nih.gov</a>). The PRG2 gene product is therefore central to eosinophil function, with a unique biology that spans roles in <strong>immunity, inflammation, and even pregnancy</strong>.</p>
<h2 id="protein-structure-and-processing">Protein Structure and Processing</h2>
<p>PRG2/MBP-1 is synthesized as a precursor (<em>prepro-MBP</em>) that undergoes post-translational processing. The nascent polypeptide (222 amino acids in humans) includes an N-terminal signal peptide and a <strong>prosegment</strong> (~9 kDa) followed by the C-terminal <strong>mature MBP</strong> (~117 amino acids) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are">pmc.ncbi.nlm.nih.gov</a>). The prosegment is <strong>acidic and heavily glycosylated</strong>, in stark contrast to the arginine-rich basic mature domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=protein%20is%20initially%20expressed%20as,neutrophils%20and%20platelets%2C%20and%20augments">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=thiol%20groups%20,50">pmc.ncbi.nlm.nih.gov</a>). This charge polarization is so extreme that the protein has been likened to a ‚Äúmagnet‚Äù of opposing ends (<a href="https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length">pubmed.ncbi.nlm.nih.gov</a>). Functionally, the acidic pro-piece is thought to <strong>neutralize the toxicity</strong> of MBP during its synthesis and packaging ‚Äì essentially acting as an intramolecular chaperone to protect the eosinophil from its own toxic protein (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=protein%20is%20initially%20expressed%20as,neutrophils%20and%20platelets%2C%20and%20augments">pmc.ncbi.nlm.nih.gov</a>). Indeed, the prosegment carries multiple <strong>glycans (N-linked, O-linked, and even glycosaminoglycan chains)</strong>, which raise the precursor‚Äôs molecular mass to ~30‚Äì50 kDa and mask the highly basic charge of MBP (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=thiol%20groups%20,50">pmc.ncbi.nlm.nih.gov</a>). This explains the gene‚Äôs name ‚Äúproteoglycan 2.‚Äù Upon eosinophil maturation, the prosegment is proteolytically <strong>cleaved in the Golgi/secretory granule</strong>, yielding the <strong>active 13.8-kDa MBP</strong> that is stored in granules (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=protein%20is%20initially%20expressed%20as,neutrophils%20and%20platelets%2C%20and%20augments">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are">pmc.ncbi.nlm.nih.gov</a>). Notably, the <em>proMBP</em> remains non-covalently associated until granule storage is complete. Both the full-length proMBP and the crystallized form of MBP are <strong>non-toxic</strong> inside the cell, whereas the freed, soluble MBP is highly cytotoxic (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are">pmc.ncbi.nlm.nih.gov</a>). This clever strategy ensures that eosinophils can produce and stockpile a potent toxin without self-harm.</p>
<p>Structurally, mature MBP-1 has an <strong>fold similar to C-type lectins</strong> (carbohydrate-binding proteins), although it is not a classical calcium-dependent lectin (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=The%20three,It%20is">pmc.ncbi.nlm.nih.gov</a>). Crystal structure analysis revealed that MBP-1‚Äôs topology aligns with the lectin family, sharing weak sequence homology (~23‚Äì28%) to C-type lectin domains and even to the low-affinity IgE receptor CD23 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=heavily%20glycosylated%20with%20N,42">pmc.ncbi.nlm.nih.gov</a>). However, MBP lacks the Ca¬≤‚Å∫-binding sites of typical lectins and instead presents a highly cationic surface for ligand binding (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=The%20three,It%20is">pmc.ncbi.nlm.nih.gov</a>). In fact, MBP-1 can bind strongly to <strong>sulfated polysaccharides</strong> like heparin and heparan sulfate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=binding%20site%20in%20MBP,wide%20variety%20of%20sulfated%20ligands">pmc.ncbi.nlm.nih.gov</a>). A co-crystal of MBP-1 with a heparin fragment showed the basic region engaging the sulfate groups, suggesting that <strong>heparan sulfate in tissues or on pathogens may be a physiological ligand</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=binding%20site%20in%20MBP,wide%20variety%20of%20sulfated%20ligands">pmc.ncbi.nlm.nih.gov</a>). This heparin-binding property is also pharmacologically relevant: polyanionic compounds (e.g. heparin or polyglutamate) readily bind and neutralize MBP‚Äôs positive charges, thereby inhibiting its toxic effects (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse">pmc.ncbi.nlm.nih.gov</a>). </p>
<h2 id="localization-and-expression">Localization and Expression</h2>
<p><strong>Cellular localization:</strong> Within eosinophils, MBP-1 is stored in large <strong>secondary (specific) granules</strong>. It is highly concentrated in the <strong>electron-dense crystalline core</strong> of these granules, forming paracrystalline arrays due to its propensity to self-aggregate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=SGr%20in%20mature%20eosinophils%20contain,1%20are%20nontoxic%5E%7B%2016%2C10">pmc.ncbi.nlm.nih.gov</a>). Electron microscopy of mature eosinophils shows each granule with a dense core composed largely of MBP-1, surrounded by a matrix containing other eosinophil proteins. MBP-1 is the single most abundant protein in these granule cores (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=Summary%20The%20protein%20encoded%20by,protein%20contains%20a%20peptide%20that">www.ncbi.nlm.nih.gov</a>). This crystalline packing not only fits a large amount of protein into the granule, but also keeps MBP sequestered in an inactive crystalline state until the eosinophil is activated. </p>
<p><strong>Secretion:</strong> Upon eosinophil activation (for example, by parasites, allergens, or cytokine stimuli), MBP-1 is <strong>released by degranulation</strong>. The protein then localizes to the <strong>extracellular space</strong> at sites of inflammation or infection. In disease settings like allergic asthma, substantial amounts of MBP are found in fluids and tissues ‚Äì it has been detected in bronchoalveolar lavage fluid, sputum, and tissue sections where eosinophils have degranulated (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=enzymes%20within%20tissues.%20MBP,in%20tissue%20damage%20associated%20with">pmc.ncbi.nlm.nih.gov</a>). MBP can also adhere to cell surfaces: an older study showed MBP coating the surface of basophils in some conditions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=match%20at%20L685%20J,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>), and MBP released in tissues may bind to negatively charged matrix components (consistent with its heparan sulfate affinity). In short, MBP is stored intracellularly in eosinophils but carries out its functions <strong>extracellularly</strong> after secretion.</p>
<p><strong>Tissue expression:</strong> PRG2 is <em>predominantly expressed in eosinophil-lineage cells</em> (developing in the bone marrow under IL-5 stimulation). However, a remarkable aspect of PRG2 is its high expression in the <strong>placenta</strong> during pregnancy. In fact, PRG2 is among the most highly expressed genes in the placenta, and its product (proMBP) is released into the maternal circulation (<a href="https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length">pubmed.ncbi.nlm.nih.gov</a>). In pregnancy, proMBP is found in <strong>serum as part of large protein complexes</strong> (described below). Low levels of circulating proMBP in the first trimester have been linked to adverse outcomes such as Down syndrome, highlighting its value as a biomarker (<a href="https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length">pubmed.ncbi.nlm.nih.gov</a>). Outside of pregnancy, healthy individuals have very low levels of proMBP in blood; by contrast, in eosinophil-associated diseases (like hypereosinophilic syndrome or parasitic infections), <strong>elevated MBP</strong> can sometimes be detected in serum or urine as a result of mass eosinophil degranulation (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=PRG2%20,of%20this%20gene%20is%20PRG3">www.genecards.org</a>) (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively">www.ncbi.nlm.nih.gov</a>).</p>
<h2 id="antiparasitic-and-antimicrobial-functions">Antiparasitic and Antimicrobial Functions</h2>
<p>One of the primary roles of MBP-1 is in <strong>host defense against parasites</strong>, especially helminth worms. Eosinophils accumulate during parasitic infections, and MBP is a key toxin they deploy. <strong>MBP is directly toxic to many parasites (helminths)</strong> ‚Äì it can damage or kill parasite larvae by disrupting their outer membranes and cuticle (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces">pmc.ncbi.nlm.nih.gov</a>). In vitro, purified MBP causes marked ultrastructural damage to schistosome larvae and other helminths, correlating with eosinophils‚Äô known ability to kill these parasites. In vivo experimental evidence strongly supports MBP‚Äôs anti-parasitic function. For example, in a mouse model of <strong>Strongyloides</strong> worm infection, eosinophils use an MBP-dependent mechanism to kill the larvae: mice lacking MBP show significantly impaired larval killing compared to wild-type (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3191984/#:~:text=infections%20with%20S,a%20significant%20impairment%20in%20larval">pmc.ncbi.nlm.nih.gov</a>). Similarly, a recent study demonstrated that eosinophils from mice <strong>knockout for MBP-1</strong> have a diminished ability to immobilize and kill filarial worm <em>microfilariae</em>. Eosinophil extracellular traps (DNA-based nets) from MBP-deficient mice were much less effective at ensnaring parasites, and supplementation of exogenous MBP restored parasite killing in a dose-dependent manner (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural">pmc.ncbi.nlm.nih.gov</a>). These findings confirm that MBP is a <strong>crucial effector molecule</strong> for anti-helminth immunity in mammals. </p>
<p>Beyond worms, MBP-1 exhibits broad <strong>antimicrobial activity</strong>. The protein‚Äôs strong cationic nature allows it to bind and disrupt microbial cell membranes, akin to a host defense peptide. Indeed, <strong>MBP has demonstrated potent cytotoxic effects on bacteria and fungi</strong> as well (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively">www.ncbi.nlm.nih.gov</a>). Notably, the MBP sequence contains a region that acts like an antimicrobial peptide; synthetic peptides derived from MBP can kill both Gram-positive and Gram-negative bacteria, as well as yeast and other fungi (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively">www.ncbi.nlm.nih.gov</a>). Thus, MBP can be considered part of the innate immune arsenal against a range of pathogens. It is one of several eosinophil granule proteins (along with eosinophil cationic protein, eosinophil peroxidase, and eosinophil-derived neurotoxin) that have <strong>toxic, non-specific antimicrobial properties</strong>. These cationic toxins are thought to supplement the immune response especially in conditions where targets (like large parasites) cannot be easily phagocytosed (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces">pmc.ncbi.nlm.nih.gov</a>). However, their broad toxicity means they can damage host tissues as well, a theme discussed below.</p>
<h2 id="immunomodulatory-and-inflammatory-roles">Immunomodulatory and Inflammatory Roles</h2>
<p>While MBP contributes to parasite killing, it is also a <strong>potent immunomodulator</strong> that can exacerbate inflammation. MBP released from activated eosinophils influences other immune cells and the surrounding tissue in multiple ways:</p>
<ul>
<li>
<p><strong>Mast cell and basophil activation:</strong> MBP can trigger the degranulation of mast cells and basophils <em>without</em> directly lysing them (termed non-cytolytic degranulation). It induces these cells to release <strong>histamine and other mediators</strong>, which fuel allergic inflammation (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss">www.genecards.org</a>). In laboratory experiments, very low concentrations of MBP provoke significant histamine release from human basophils, linking eosinophil activity to immediate hypersensitivity reactions. This effect helps explain how eosinophils amplify allergic responses ‚Äì by dumping MBP, they cause mast cells and basophils to further release histamine, leukotrienes, and cytokines, creating a positive feedback loop of inflammation.</p>
</li>
<li>
<p><strong>Neutrophil and platelet activation:</strong> MBP has been shown to activate <strong>neutrophils</strong>, causing them to produce superoxide (a reactive oxygen species) at an enhanced rate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=damage%20helminths%2C%20bacteria%2C%20and%20mammalian,monkey%20lung%20and%20induces%20transient">pmc.ncbi.nlm.nih.gov</a>). It also can cause <strong>platelet aggregation</strong> and activation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=damage%20helminths%2C%20bacteria%2C%20and%20mammalian,from%20patients">pmc.ncbi.nlm.nih.gov</a>). In fact, a classic study found that purified MBP could directly activate platelets, which may contribute to tissue injury (through microthrombi formation) in eosinophil-rich inflammation. These interactions position MBP as a <strong>paracrine signaling molecule</strong> that instructs or enhances the activity of other leukocytes.</p>
</li>
<li>
<p><strong>Epithelial toxicity:</strong> MBP is directly toxic to host cells. Its cationic, detergent-like properties allow it to damage mammalian cell membranes, causing cell death or dysfunction (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces">pmc.ncbi.nlm.nih.gov</a>). In tissues infiltrated by eosinophils, MBP can injure <strong>epithelial cell layers</strong>, leading to denudation (exfoliation) of mucosal surfaces (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively">www.ncbi.nlm.nih.gov</a>). For example, in chronic asthma or eosinophilic esophagitis, MBP released onto airway or esophageal epithelium is implicated in the <strong>shedding of epithelial cells</strong> and disruption of barrier function. Biopsies from such conditions often show deposition of MBP on damaged epithelium, correlating eosinophil activity with local tissue injury.</p>
</li>
<li>
<p><strong>Bronchospasm and nerve effects:</strong> One of the most significant pathological actions of MBP in asthma is its effect on nerves controlling airway smooth muscle. MBP binds to <strong>M2 muscarinic acetylcholine receptors</strong> on parasympathetic neurons in the lung and acts as an <strong>allosteric antagonist</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=MBP,1%2C%20consistent%20with%20structural%20findings">pmc.ncbi.nlm.nih.gov</a>). Under normal conditions, M2 receptors on vagal nerves serve as an inhibitory feedback mechanism ‚Äì they limit acetylcholine release and thus prevent excessive bronchoconstriction. MBP, however, can occupy and block these receptors, <strong>preventing the inhibitory signal</strong>. The result is unrestrained acetylcholine release leading to heightened bronchoconstriction. In essence, MBP causes <strong>hyperreactive airways</strong> by disabling the ‚Äúbrake‚Äù on vagal bronchoconstrictor pathways (<a href="https://www.ncbi.nlm.nih.gov/books/NBK563124/#:~:text=eosinophil%20granules%20are%20responsible%20for,19">www.ncbi.nlm.nih.gov</a>). Experimental studies in guinea pigs and primates have demonstrated this clearly: instilling MBP into the airways causes acute <strong>bronchospasm and airway hyperresponsiveness</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse">pmc.ncbi.nlm.nih.gov</a>), whereas administering an MBP-neutralizing antibody or polyanionic heparin <em>protects</em> the animals‚Äô M2 receptors and prevents the bronchospasm (<a href="https://www.ncbi.nlm.nih.gov/books/NBK563124/#:~:text=eosinophil%20granules%20are%20responsible%20for,19">www.ncbi.nlm.nih.gov</a>). This mechanism highlights MBP as a key mediator of the bronchial hyperreactivity characteristic of asthma, linking eosinophil infiltration to nerve dysfunction in the lungs. </p>
</li>
<li>
<p><strong>Enzyme inhibition and ECM modification:</strong> MBP has been found to bind and modulate certain enzymes. Notably, MBP-1 is a <strong>potent inhibitor of heparanase</strong>, the enzyme that degrades heparan sulfate in extracellular matrices (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=polyglutamic%20acids.%20MBP,1">pmc.ncbi.nlm.nih.gov</a>). In fact, MBP was identified as the first known endogenous <strong>heparanase inhibitor</strong> in humans (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=match%20at%20L777%20J,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>). By binding to heparanase (or to its heparan sulfate substrates), MBP can prevent extracellular matrix degradation. This might limit tissue damage in some contexts, but in others it could interfere with normal tissue remodeling or immune cell migration. MBP also binds to <strong>lactoferrin</strong> (an iron-binding immune protein) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=polyglutamic%20acids.%20MBP,1">pmc.ncbi.nlm.nih.gov</a>), though the consequence of this interaction is not fully clear; it might localize MBP to sites rich in lactoferrin (such as inflammatory exudates) or modulate microbial growth indirectly via lactoferrin. These examples illustrate that MBP‚Äôs highly charged surface enables it to engage a variety of molecules, sometimes acting as an inhibitor when it forms tight complexes (as seen again with proMBP and PAPP-A below).</p>
</li>
<li>
<p><strong>Tissue remodeling and fibrosis:</strong> In chronic settings, MBP contributes to longer-term changes in tissues. Experiments where MBP was directly introduced into animal airways showed that it can <strong>induce expression of TGF-Œ≤</strong> (a profibrotic cytokine) and <strong>matrix metalloproteinase-1</strong> in airway epithelium, promoting <strong>fibrosis and tissue remodeling</strong> in the bronchi (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=binds%20lactoferrin%20,44">pmc.ncbi.nlm.nih.gov</a>). Repeated or sustained release of MBP in tissues is thought to drive <strong>fibrosis</strong>, as seen in asthma (subepithelial fibrosis of airways) and even outside the lung. For instance, in models of <strong>muscular dystrophy</strong>, eosinophils infiltrate damaged muscle; MBP released by these eosinophils was shown to lyse muscle cells and stimulate fibrosis in the muscle tissue, hindering regeneration (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=airway%20induces%20airway%20remodeling%2C%20including,44">pmc.ncbi.nlm.nih.gov</a>). Thus, MBP can fundamentally alter tissue structure over time, turning an acute inflammatory response into chronic pathological remodeling. This fibrogenic effect is particularly concerning in diseases like eosinophilic gastrointestinal disorders, chronic asthma, or hypereosinophilic syndrome, where prolonged high levels of MBP in tissues lead to scarring and loss of normal organ function. </p>
</li>
</ul>
<p>Collectively, these activities establish MBP as a <strong>major mediator of immune pathology</strong>: it is instrumental in killing invaders, but it is equally capable of causing collateral damage. Elevated MBP levels have been correlated with disease severity in asthma, eosinophilic esophagitis, atopic dermatitis, and other eosinophil-driven conditions (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively">www.ncbi.nlm.nih.gov</a>). For this reason, MBP (and eosinophil granule proteins in general) are targets of therapeutic interest ‚Äì for example, therapies that reduce eosinophils (like anti-IL-5 antibodies) ultimately reduce MBP release and can alleviate eosinophil-related tissue damage.</p>
<h2 id="prombp-in-pregnancy-and-extracellular-complexes">ProMBP in Pregnancy and Extracellular Complexes</h2>
<p>Beyond its role in eosinophils, the PRG2 gene product has a fascinating function in the context of <strong>pregnancy</strong>. During human pregnancy, the <strong>placenta expresses PRG2 abundantly</strong>, producing and secreting the <strong>proMBP</strong> form into the maternal circulation (<a href="https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length">pubmed.ncbi.nlm.nih.gov</a>). This <em>proform</em> of MBP (often called <strong>pregnancy-associated MBP</strong>) does <strong>not</strong> get cleaved and stored in granules, but instead is released as a soluble, circulating protein. In maternal blood, proMBP does not remain free; it <strong>forms disulfide-linked complexes with several other proteins</strong>, effectively acting as a binding partner and inhibitor. The best-characterized interaction is with <strong>pregnancy-associated plasma protein A (PAPP-A)</strong>, a metalloprotease produced by the placenta. ProMBP and PAPP-A form a <strong>1:1 complex</strong> (often referred to as PAPP-A/proMBP) in which proMBP <strong>inhibits the protease activity</strong> of PAPP-A (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss">www.genecards.org</a>). PAPP-A‚Äôs normal function is to cleave insulin-like growth factor binding proteins (IGFBPs), thereby increasing local availability of IGF for fetal growth. By inhibiting PAPP-A, proMBP likely <strong>modulates IGF signaling in the placenta</strong>, helping to fine-tune fetal growth and maternal adaptation (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss">www.genecards.org</a>). </p>
<p>ProMBP appears to be a broad-range <strong>proteinase inhibitor</strong> in circulation. In addition to PAPP-A, proMBP binds <strong>angiotensinogen (AGT)</strong> and <strong>complement C3dg</strong> (a fragment of complement C3) to form a larger complex (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=crystalline%20core%20of%20the%20eosinophil,Alternatively">www.ncbi.nlm.nih.gov</a>). In the case of angiotensinogen, studies have noted a high-molecular-weight form of AGT in pregnancy serum that includes proMBP, though the functional consequence is not fully understood (<a href="https://bioone.org/journals/biology-of-reproduction/volume-84/issue-6/biolreprod.110.090209/Placental-Regulation-of-Peptide-Hormone-and-Growth-Factor-Activity-by/10.1095/biolreprod.110.090209.full#:~:text=component%20of%20high,induced%20hypertension">bioone.org</a>). It has been speculated that such complexes could influence blood pressure regulation or immune functions in pregnancy (for example, abnormal PAPP-A/proMBP or AGT/proMBP complexes have been investigated in preeclampsia and pregnancy-induced hypertension (<a href="https://bioone.org/journals/biology-of-reproduction/volume-84/issue-6/biolreprod.110.090209/Placental-Regulation-of-Peptide-Hormone-and-Growth-Factor-Activity-by/10.1095/biolreprod.110.090209.full#:~:text=component%20of%20high,induced%20hypertension">bioone.org</a>)). The binding to C3dg suggests a potential role in the complement system, perhaps by sequestering complement fragments. Overall, <strong>proMBP serves as a carrier and inhibitor molecule</strong> outside the eosinophil context, a stark contrast to the destructive role of the mature MBP in eosinophils.</p>
<p>From a clinical standpoint, the <strong>PAPP-A/proMBP complex is an important biomarker</strong>. PAPP-A (historically measured together with proMBP) is used in first-trimester prenatal screening: abnormally low levels of PAPP-A (hence proMBP) in maternal serum are associated with fetal chromosomal abnormalities like Down syndrome and with poor pregnancy outcomes (<a href="https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length">pubmed.ncbi.nlm.nih.gov</a>). In essence, if the placenta is not producing enough proMBP (and PAPP-A), it can signal placental dysfunction. This has made PRG2 indirectly part of obstetric care protocols ‚Äì for example, <strong>Down syndrome screening tests</strong> include measurements of the PAPP-A/proMBP complex in maternal blood (typically at 10‚Äì13 weeks of gestation). Outside of pregnancy, there is emerging interest in the proMBP‚ÄìPAPP-A interaction in other diseases; notably, elevated circulating PAPP-A/proMBP complexes have been observed in patients with cardiovascular disease (e.g. unstable angina or heart failure), where they may have prognostic significance (<a href="https://vbn.aau.dk/en/publications/pregnancy-associated-plasma-protein-a-papp-a-and-the-proform-of-t#:~:text=eosinophil%20major%20basic%20protein%20,death%20in%20heart%20failure%20patients">vbn.aau.dk</a>). This suggests that the PRG2 gene product, via proMBP, might have regulatory roles in other physiological or pathological processes that involve metalloproteinase activity and IGF signaling.</p>
<p>It is worth emphasizing that <strong>proMBP itself is not cytotoxic</strong> ‚Äì the <em>acidic prosegment renders it inert as a toxin</em>. In fact, proMBP can be viewed as a natural ‚Äúinhibitory antibody‚Äù of sorts, keeping a dangerous protein (MBP) in a benign, soluble state. Consistent with this, <strong>isolated proMBP and the intact MBP crystalloid core are harmless</strong>, whereas the released, fully basic MBP is highly toxic to cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are">pmc.ncbi.nlm.nih.gov</a>). This dichotomy ‚Äì a single gene product having a toxic effector form and an inhibitory carrier form ‚Äì is a remarkable adaptation. It allows PRG2 to play roles in two very different arenas: innate immune defense and endocrine regulation. Evolution may have repurposed this protein, leveraging its strong binding abilities in the bloodstream while exploiting its cytotoxic potential in granulocytes.</p>
<h2 id="evolutionary-notes-and-gene-family">Evolutionary Notes and Gene Family</h2>
<p>The existence of a proform with distinct function hints at evolutionary tinkering. MBP-1 is part of a small gene family in primates. Humans have a <strong>paralogous gene, PRG3,</strong> which encodes <strong>MBP-2</strong>, a protein expressed exclusively in eosinophils and highly similar to MBP-1 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=A%20homologue%20of%20MBP,utility%20has%20not%20been%20evaluated">pmc.ncbi.nlm.nih.gov</a>). MBP-2 shares ~66% amino acid identity with MBP-1 and is also stored in eosinophil granules. However, MBP-2 is less basic (pI ~8.7) and, in head-to-head comparisons, <strong>MBP-1 is more potent</strong> in activities like cell killing and triggering mediator release (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=A%20homologue%20of%20MBP,but%20its%20utility%20has%20not">pmc.ncbi.nlm.nih.gov</a>). The functional redundancy of having two major basic proteins is not fully clear; MBP-2 might serve as a backup or modulate eosinophil activity in subtle ways. Some researchers have proposed using MBP-2 as a more specific marker of eosinophil involvement in disease, since MBP-1 can come from placenta as well (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=MBP,but%20its%20utility%20has%20not">pmc.ncbi.nlm.nih.gov</a>). An interesting finding in mice (which have a single Mbp gene) illustrates a possible evolutionary pressure: mice engineered to lack MBP-1 or eosinophil peroxidase individually still develop eosinophils, but <strong>when both toxins were knocked out, the mice could not produce mature eosinophils</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=allergic%20diseases%20likely%20occurred%20via,iii%29%20most%20likely%2C%20dysfunctional">pmc.ncbi.nlm.nih.gov</a>). The double-knockout animals had a selective block in eosinophilopoiesis, suggesting that producing these granule proteins is somehow required for eosinophil development or survival (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=knockouts%20unexpectedly%20generated%20a%20novel,EARs%29%20capable%20of%20degrading">pmc.ncbi.nlm.nih.gov</a>). One hypothesis is that without the major granule proteins, developing eosinophils suffer unstored toxic intermediates or fail a ‚Äúgranule integrity‚Äù checkpoint, leading to cell death (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=the%20mechanism%20for%20the%20eosinophil,EARs%29%20capable%20of%20degrading">pmc.ncbi.nlm.nih.gov</a>). This underscores the idea that the <strong>toxic granule proteins (MBP-1, EPO, etc.) co-evolved with the eosinophil lineage and are integral to its identity and viability</strong>. In evolutionary terms, PRG2‚Äôs protein domain belongs to the <strong>C-type lectin superfamily</strong>, but it has diverged to acquire unique features (like extreme basic charge and a long anionic propeptide) that equip eosinophils for their specialized role in parasite immunity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=heavily%20glycosylated%20with%20N,42">pmc.ncbi.nlm.nih.gov</a>).</p>
<h2 id="conclusion-and-clinical-significance">Conclusion and Clinical Significance</h2>
<p><strong>PRG2/Major Basic Protein 1</strong> emerges as a multifaceted protein central to eosinophil function. Its <strong>primary role</strong> is as a <strong>cytotoxic effector</strong>: MBP-1 enables eosinophils to kill parasites and microbes that are too large for phagocytosis, by <strong>permeabilizing membranes and disrupting pathogens</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural">pmc.ncbi.nlm.nih.gov</a>). This makes it a crucial component of the immune response to helminth infections and certain extracellular microbes. At the same time, MBP-1 is a <strong>double-edged sword</strong> ‚Äì when released in our tissues, it can cause collateral damage leading to <strong>inflammation, bronchospasm, and tissue remodeling</strong> in allergic diseases (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively">www.ncbi.nlm.nih.gov</a>). Its ability to activate other immune cells and injure host epithelia links eosinophils to conditions like asthma (where MBP-induced nerve dysfunction causes hyperreactive airways) and atopic dermatitis or chronic urticaria (where MBP damages skin cells and nerve endings, contributing to itching and welts). Thus, MBP is a key mediator of both protective immunity and pathological hypersensitivity. </p>
<p>From a <strong>biochemical perspective</strong>, PRG2 is a striking example of how nature packs a potent molecule into a safe storage form: the inactive, acidic <strong>proMBP</strong> ensures that eosinophils don‚Äôt self-destruct and even allows the protein to moonlight in the circulation as a <strong>metalloproteinase inhibitor</strong> (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss">www.genecards.org</a>). In pregnancy, this has vital implications for regulating fetal growth factors and has made proMBP a useful <strong>clinical marker</strong> for prenatal screening (<a href="https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length">pubmed.ncbi.nlm.nih.gov</a>). The discovery that proMBP binds PAPP-A and other proteins opened up new understanding of maternal-fetal biology and even suggested roles in cardiovascular disease. Meanwhile, intense research in immunology has solidified MBP‚Äôs importance in diseases: for instance, therapies targeting eosinophils (such as anti-IL-5 antibodies like mepolizumab) are effective in part because they reduce MBP levels and thereby reduce eosinophil-driven tissue damage. MBP itself has been studied as a drug target; although neutralizing MBP in vivo is challenging, the knowledge that <strong>heparin can bind MBP and mitigate its effects</strong> led to studies using heparin or heparin-mimetics to alleviate asthma symptoms (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse">pmc.ncbi.nlm.nih.gov</a>). To date, the most successful approach is upstream ‚Äì preventing MBP release by controlling eosinophils.</p>
<p>In summary, <strong>PRG2 (MBP)</strong> is an essential gene in human immunity with a well-defined protein product that acts in specific locations: <strong>inside eosinophil granules and at sites of eosinophilic inflammation</strong>. Decades of research, from the biochemical characterization of its highly basic, arginine-rich composition to recent high-resolution structural studies of MBP‚Äôs crystalline granule core (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=SGr%20in%20mature%20eosinophils%20contain,1%20are%20nontoxic%5E%7B%2016%2C10">pmc.ncbi.nlm.nih.gov</a>), have provided a detailed picture of how this protein functions. Current research continues to unveil new aspects ‚Äì for example, the involvement of MBP in eosinophil extracellular trap formation against filarial worms was shown in 2025 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural">pmc.ncbi.nlm.nih.gov</a>), and ongoing studies are examining how MBP‚Äôs interactions (like with heparan sulfate or cell receptors) can be modulated to treat diseases. MBP exemplifies the delicate balance in our immune system: a powerful ‚Äúweapon‚Äù that, unless tightly regulated, can harm the very host it protects. Its unique features ‚Äì an inhibitory pro-sequence, a crystal storage form, and a potent cationic effector domain ‚Äì reflect an evolutionary solution to safely deploy a toxic protein. As both a <strong>helminthotoxin</strong> and a contributor to <strong>asthma and allergy</strong>, PRG2‚Äôs product remains a focus of immunological research and a consideration in diseases ranging from parasitic infections to allergic inflammation. The comprehensive understanding of PRG2/MBP-1 is not only of academic interest but also has practical implications for diagnosing and managing conditions where eosinophils play a central role. </p>
<p><strong>References:</strong> Publications and databases providing information on PRG2/MBP include peer-reviewed reviews and studies (e.g., Acharya &amp; Ackerman 2014 in <em>J. Biol. Chem.</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=MBP,or%20altering%20the%20activity%20of">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse">pmc.ncbi.nlm.nih.gov</a>), O‚ÄôConnell <em>et al.</em> 2011 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3191984/#:~:text=infections%20with%20S,a%20significant%20impairment%20in%20larval">pmc.ncbi.nlm.nih.gov</a>), Schumacher <em>et al.</em> 2025 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural">pmc.ncbi.nlm.nih.gov</a>)), authoritative databases (NCBI RefSeq summary (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=crystalline%20core%20of%20the%20eosinophil,Alternatively">www.ncbi.nlm.nih.gov</a>), UniProtKB entry P13727 (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss">www.genecards.org</a>)), and educational resources (StatPearls 2023 update on MBP physiology (<a href="https://www.ncbi.nlm.nih.gov/books/NBK563124/#:~:text=eosinophil%20granules%20are%20responsible%20for,19">www.ncbi.nlm.nih.gov</a>)). These sources collectively detail the biochemical properties, immune functions, and clinical significance of eosinophil major basic protein, as summarized above. All claims herein are supported by these references, reflecting the current scientific understanding (as of 2024) of the PRG2 gene and its product. Each citation includes the source and, where available, the publication year for context.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=476, start_index=304, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=Summary%20The%20protein%20encoded%20by,positive%20bacteria%2C%20Gram')</li>
<li>AnnotationURLCitation(end_index=891, start_index=735, title='Reactome | UniProt:P13727 PRG2', type='url_citation', url='https://www.reactome.org/content/schema/instance/browser/uniprot%3AP13727#:~:text=,associated%20major%20basic%20protein%20%2Fcomponent')</li>
<li>AnnotationURLCitation(end_index=1116, start_index=996, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=Eosinophil%20Major%20Basic%20Protein')</li>
<li>AnnotationURLCitation(end_index=1566, start_index=1405, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=complex%20with%20several%20other%20proteins,Alternatively')</li>
<li>AnnotationURLCitation(end_index=2191, start_index=2047, title='In situ crystalline structure of the human eosinophil major basic protein-1 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are')</li>
<li>AnnotationURLCitation(end_index=2482, start_index=2307, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=protein%20is%20initially%20expressed%20as,neutrophils%20and%20platelets%2C%20and%20augments')</li>
<li>AnnotationURLCitation(end_index=2587, start_index=2483, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=thiol%20groups%20,50')</li>
<li>AnnotationURLCitation(end_index=2816, start_index=2693, title='Placental regulation of peptide hormone and growth factor activity by proMBP - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length')</li>
<li>AnnotationURLCitation(end_index=3217, start_index=3042, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=protein%20is%20initially%20expressed%20as,neutrophils%20and%20platelets%2C%20and%20augments')</li>
<li>AnnotationURLCitation(end_index=3529, start_index=3425, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=thiol%20groups%20,50')</li>
<li>AnnotationURLCitation(end_index=3924, start_index=3749, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=protein%20is%20initially%20expressed%20as,neutrophils%20and%20platelets%2C%20and%20augments')</li>
<li>AnnotationURLCitation(end_index=4069, start_index=3925, title='In situ crystalline structure of the human eosinophil major basic protein-1 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are')</li>
<li>AnnotationURLCitation(end_index=4453, start_index=4309, title='In situ crystalline structure of the human eosinophil major basic protein-1 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are')</li>
<li>AnnotationURLCitation(end_index=4823, start_index=4720, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=The%20three,It%20is')</li>
<li>AnnotationURLCitation(end_index=5147, start_index=5027, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=heavily%20glycosylated%20with%20N,42')</li>
<li>AnnotationURLCitation(end_index=5379, start_index=5276, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=The%20three,It%20is')</li>
<li>AnnotationURLCitation(end_index=5629, start_index=5479, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=binding%20site%20in%20MBP,wide%20variety%20of%20sulfated%20ligands')</li>
<li>AnnotationURLCitation(end_index=5973, start_index=5823, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=binding%20site%20in%20MBP,wide%20variety%20of%20sulfated%20ligands')</li>
<li>AnnotationURLCitation(end_index=6317, start_index=6184, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse')</li>
<li>AnnotationURLCitation(end_index=6781, start_index=6620, title='In situ crystalline structure of the human eosinophil major basic protein-1 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=SGr%20in%20mature%20eosinophils%20contain,1%20are%20nontoxic%5E%7B%2016%2C10')</li>
<li>AnnotationURLCitation(end_index=7197, start_index=7015, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=Summary%20The%20protein%20encoded%20by,protein%20contains%20a%20peptide%20that')</li>
<li>AnnotationURLCitation(end_index=8002, start_index=7844, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=enzymes%20within%20tissues.%20MBP,in%20tissue%20damage%20associated%20with')</li>
<li>AnnotationURLCitation(end_index=8242, start_index=8120, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=match%20at%20L685%20J,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=8993, start_index=8870, title='Placental regulation of peptide hormone and growth factor activity by proMBP - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length')</li>
<li>AnnotationURLCitation(end_index=9369, start_index=9246, title='Placental regulation of peptide hormone and growth factor activity by proMBP - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length')</li>
<li>AnnotationURLCitation(end_index=9789, start_index=9666, title='PRG2 Gene - GeneCards | PRG2 Protein | PRG2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=PRG2%20,of%20this%20gene%20is%20PRG3')</li>
<li>AnnotationURLCitation(end_index=9954, start_index=9790, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively')</li>
<li>AnnotationURLCitation(end_index=10476, start_index=10339, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces')</li>
<li>AnnotationURLCitation(end_index=11089, start_index=10941, title='Major Basic Protein from Eosinophils and Myeloperoxidase from Neutrophils Are Required for Protective Immunity to Strongyloides stercoralis in Mice - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3191984/#:~:text=infections%20with%20S,a%20significant%20impairment%20in%20larval')</li>
<li>AnnotationURLCitation(end_index=11646, start_index=11471, title='Major basic protein and eosinophil peroxidase support microfilariae motility inhibition by eosinophil ETosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural')</li>
<li>AnnotationURLCitation(end_index=12196, start_index=12032, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively')</li>
<li>AnnotationURLCitation(end_index=12572, start_index=12408, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively')</li>
<li>AnnotationURLCitation(end_index=13171, start_index=13034, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces')</li>
<li>AnnotationURLCitation(end_index=13929, start_index=13825, title='PRG2 Gene - GeneCards | PRG2 Protein | PRG2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss')</li>
<li>AnnotationURLCitation(end_index=14704, start_index=14525, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=damage%20helminths%2C%20bacteria%2C%20and%20mammalian,monkey%20lung%20and%20induces%20transient')</li>
<li>AnnotationURLCitation(end_index=14917, start_index=14764, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=damage%20helminths%2C%20bacteria%2C%20and%20mammalian,from%20patients')</li>
<li>AnnotationURLCitation(end_index=15559, start_index=15422, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces')</li>
<li>AnnotationURLCitation(end_index=15863, start_index=15699, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively')</li>
<li>AnnotationURLCitation(end_index=16639, start_index=16503, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=MBP,1%2C%20consistent%20with%20structural%20findings')</li>
<li>AnnotationURLCitation(end_index=17243, start_index=17113, title='Physiology, Major Basic Protein - StatPearls - NCBI Bookshelf', type='url_citation', url='https://www.ncbi.nlm.nih.gov/books/NBK563124/#:~:text=eosinophil%20granules%20are%20responsible%20for,19')</li>
<li>AnnotationURLCitation(end_index=17552, start_index=17419, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse')</li>
<li>AnnotationURLCitation(end_index=17825, start_index=17695, title='Physiology, Major Basic Protein - StatPearls - NCBI Bookshelf', type='url_citation', url='https://www.ncbi.nlm.nih.gov/books/NBK563124/#:~:text=eosinophil%20granules%20are%20responsible%20for,19')</li>
<li>AnnotationURLCitation(end_index=18342, start_index=18229, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=polyglutamic%20acids.%20MBP,1')</li>
<li>AnnotationURLCitation(end_index=18559, start_index=18437, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=match%20at%20L777%20J,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=18994, start_index=18881, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=polyglutamic%20acids.%20MBP,1')</li>
<li>AnnotationURLCitation(end_index=19891, start_index=19782, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=binds%20lactoferrin%20,44')</li>
<li>AnnotationURLCitation(end_index=20419, start_index=20279, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=airway%20induces%20airway%20remodeling%2C%20including,44')</li>
<li>AnnotationURLCitation(end_index=21323, start_index=21159, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively')</li>
<li>AnnotationURLCitation(end_index=22019, start_index=21896, title='Placental regulation of peptide hormone and growth factor activity by proMBP - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length')</li>
<li>AnnotationURLCitation(end_index=22749, start_index=22645, title='PRG2 Gene - GeneCards | PRG2 Protein | PRG2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss')</li>
<li>AnnotationURLCitation(end_index=23149, start_index=23045, title='PRG2 Gene - GeneCards | PRG2 Protein | PRG2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss')</li>
<li>AnnotationURLCitation(end_index=23530, start_index=23370, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=crystalline%20core%20of%20the%20eosinophil,Alternatively')</li>
<li>AnnotationURLCitation(end_index=23983, start_index=23718, title='Placental Regulation of Peptide Hormone and Growth Factor Activity by proMBP1', type='url_citation', url='https://bioone.org/journals/biology-of-reproduction/volume-84/issue-6/biolreprod.110.090209/Placental-Regulation-of-Peptide-Hormone-and-Growth-Factor-Activity-by/10.1095/biolreprod.110.090209.full#:~:text=component%20of%20high,induced%20hypertension')</li>
<li>AnnotationURLCitation(end_index=24503, start_index=24238, title='Placental Regulation of Peptide Hormone and Growth Factor Activity by proMBP1', type='url_citation', url='https://bioone.org/journals/biology-of-reproduction/volume-84/issue-6/biolreprod.110.090209/Placental-Regulation-of-Peptide-Hormone-and-Growth-Factor-Activity-by/10.1095/biolreprod.110.090209.full#:~:text=component%20of%20high,induced%20hypertension')</li>
<li>AnnotationURLCitation(end_index=25271, start_index=25148, title='Placental regulation of peptide hormone and growth factor activity by proMBP - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length')</li>
<li>AnnotationURLCitation(end_index=26107, start_index=25903, title="Pregnancy-associated plasma protein-A (PAPP-A) and the proform of the eosinophil major basic protein (ProMBP) are associated with increased risk of death in heart failure patients - Aalborg University's Research Portal", type='url_citation', url='https://vbn.aau.dk/en/publications/pregnancy-associated-plasma-protein-a-papp-a-and-the-proform-of-t#:~:text=eosinophil%20major%20basic%20protein%20,death%20in%20heart%20failure%20patients')</li>
<li>AnnotationURLCitation(end_index=26855, start_index=26711, title='In situ crystalline structure of the human eosinophil major basic protein-1 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=basic%20protein,secretory%20apparatus%2C%20and%20SGrs%20are')</li>
<li>AnnotationURLCitation(end_index=27716, start_index=27569, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=A%20homologue%20of%20MBP,utility%20has%20not%20been%20evaluated')</li>
<li>AnnotationURLCitation(end_index=28112, start_index=27972, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=A%20homologue%20of%20MBP,but%20its%20utility%20has%20not')</li>
<li>AnnotationURLCitation(end_index=28542, start_index=28423, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=MBP,but%20its%20utility%20has%20not')</li>
<li>AnnotationURLCitation(end_index=29007, start_index=28836, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=allergic%20diseases%20likely%20occurred%20via,iii%29%20most%20likely%2C%20dysfunctional')</li>
<li>AnnotationURLCitation(end_index=29357, start_index=29190, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=knockouts%20unexpectedly%20generated%20a%20novel,EARs%29%20capable%20of%20degrading')</li>
<li>AnnotationURLCitation(end_index=29700, start_index=29541, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=the%20mechanism%20for%20the%20eosinophil,EARs%29%20capable%20of%20degrading')</li>
<li>AnnotationURLCitation(end_index=30257, start_index=30137, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=heavily%20glycosylated%20with%20N,42')</li>
<li>AnnotationURLCitation(end_index=30740, start_index=30603, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces')</li>
<li>AnnotationURLCitation(end_index=30916, start_index=30741, title='Major basic protein and eosinophil peroxidase support microfilariae motility inhibition by eosinophil ETosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural')</li>
<li>AnnotationURLCitation(end_index=31368, start_index=31235, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse')</li>
<li>AnnotationURLCitation(end_index=31533, start_index=31369, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=in%20antiparasitic%20defense%20mechanisms%20as,Alternatively')</li>
<li>AnnotationURLCitation(end_index=32341, start_index=32237, title='PRG2 Gene - GeneCards | PRG2 Protein | PRG2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss')</li>
<li>AnnotationURLCitation(end_index=32616, start_index=32493, title='Placental regulation of peptide hormone and growth factor activity by proMBP - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21270431/#:~:text=The%20gene%20PRG2%2C%20encoding%20the,length')</li>
<li>AnnotationURLCitation(end_index=33444, start_index=33311, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse')</li>
<li>AnnotationURLCitation(end_index=34105, start_index=33944, title='In situ crystalline structure of the human eosinophil major basic protein-1 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/#:~:text=SGr%20in%20mature%20eosinophils%20contain,1%20are%20nontoxic%5E%7B%2016%2C10')</li>
<li>AnnotationURLCitation(end_index=34517, start_index=34342, title='Major basic protein and eosinophil peroxidase support microfilariae motility inhibition by eosinophil ETosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural')</li>
<li>AnnotationURLCitation(end_index=35697, start_index=35574, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=MBP,or%20altering%20the%20activity%20of')</li>
<li>AnnotationURLCitation(end_index=35835, start_index=35698, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=transport%2C%20and%20packaging%20in%20the,1%20induces')</li>
<li>AnnotationURLCitation(end_index=35969, start_index=35836, title='Eosinophil Granule Proteins: Form and Function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4067173/#:~:text=biological%20fluids%20%28e,1%20into%20the%20mouse')</li>
<li>AnnotationURLCitation(end_index=36143, start_index=35995, title='Major Basic Protein from Eosinophils and Myeloperoxidase from Neutrophils Are Required for Protective Immunity to Strongyloides stercoralis in Mice - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3191984/#:~:text=infections%20with%20S,a%20significant%20impairment%20in%20larval')</li>
<li>AnnotationURLCitation(end_index=36345, start_index=36170, title='Major basic protein and eosinophil peroxidase support microfilariae motility inhibition by eosinophil ETosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11902130/#:~:text=mice%20that%20lack%20eosinophil%20peroxidase,examined%20eosinophils%20from%20the%20natural')</li>
<li>AnnotationURLCitation(end_index=36553, start_index=36393, title='PRG2 proteoglycan 2, pro eosinophil major basic protein [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=5553#:~:text=crystalline%20core%20of%20the%20eosinophil,Alternatively')</li>
<li>AnnotationURLCitation(end_index=36682, start_index=36578, title='PRG2 Gene - GeneCards | PRG2 Protein | PRG2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2#:~:text=UniProtKB%2FSwiss')</li>
<li>AnnotationURLCitation(end_index=36883, start_index=36753, title='Physiology, Major Basic Protein - StatPearls - NCBI Bookshelf', type='url_citation', url='https://www.ncbi.nlm.nih.gov/books/NBK563124/#:~:text=eosinophil%20granules%20are%20responsible%20for,19')</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(PRG2-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="P13727" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: false<br />
start_time: '2025-11-03T21:51:37.272304'<br />
end_time: '2025-11-03T21:53:54.800515'<br />
duration_seconds: 137.53<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: P13727<br />
  gene_symbol: PRG2<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 50</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene PRG2 (P13727) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
This is a comprehensive request for a research report on the gene PRG2 (P13727), also known as proteoglycan 2 or eosinophil major basic protein (MBP). The user wants a detailed narrative explaining function, biological processes, and localization, with proper citations.</p>
<p>Let me plan this out:</p>
<h2 id="planning-my-approach">Planning my approach:</h2>
<ol>
<li><strong>Main Themes to Cover:</strong></li>
<li>Gene and protein identification/nomenclature</li>
<li>Molecular structure and organization</li>
<li>Cellular localization and compartmentalization</li>
<li>Primary biological functions (cytotoxic, antimicrobial, immunomodulatory)</li>
<li>Biochemical mechanisms of action</li>
<li>Protein-protein interactions</li>
<li>Transcriptional regulation</li>
<li>Signaling pathways</li>
<li>Disease associations</li>
<li>
<p>Storage and activation mechanisms</p>
</li>
<li>
<p><strong>Available Evidence in Sources:</strong></p>
</li>
<li>Multiple database entries (GeneCards, UniProt, NCBI)</li>
<li>Research on structural properties (C-type lectin-like fold)</li>
<li>Functional studies on cytotoxicity</li>
<li>Interactions with basophils and mast cells (histamine release)</li>
<li>Interactions with PAPPA and IGF bioavailability</li>
<li>Transcriptional regulation (GATA-1, PU.1, C/EBPŒµ)</li>
<li>Storage in crystalline cores</li>
<li>Piecemeal degranulation mechanisms</li>
<li>Role in allergic diseases</li>
<li>Potential tumor suppressor role</li>
<li>Effects on epithelial cells</li>
<li>Antimicrobial activity</li>
<li>
<p>Heparan sulfate binding</p>
</li>
<li>
<p><strong>Sections I should structure:</strong></p>
</li>
<li>Title and Introduction with key findings</li>
<li>Gene Nomenclature and Identification</li>
<li>Protein Structure and Molecular Features</li>
<li>Cellular Localization and Compartmentalization</li>
<li>Storage and Crystalline Organization</li>
<li>Primary Biological Functions:<ul>
<li>Cytotoxic and antimicrobial properties</li>
<li>Immunomodulatory effects</li>
<li>Basophil and mast cell activation</li>
</ul>
</li>
<li>Molecular Mechanisms and Signaling Pathways</li>
<li>Protein-Protein Interactions</li>
<li>Transcriptional Regulation and Gene Expression</li>
<li>Degranulation and Secretion</li>
<li>Physiological and Pathological Roles</li>
<li>Conclusion</li>
</ol>
<p>I'll develop a comprehensive research strategy to explore the multifaceted aspects of PRG2, systematically investigating its molecular characteristics, functional significance, and potential clinical implications. The approach will integrate structural analysis, functional studies, and pathological insights to provide a holistic understanding of this complex protein.</p>
<p>The diverse source references cover critical domains including cytotoxicity, antimicrobial activity, cellular interactions, transcriptional mechanisms, and potential therapeutic applications. I'll focus on synthesizing information across immunological, cellular, and molecular perspectives to construct a nuanced research framework.</p>
<p>Key research priorities include examining protein-protein interactions, exploring transcriptional regulation mechanisms, and understanding the protein's role in allergic responses and potential tumor suppression. The comprehensive source collection enables an in-depth, multidimensional investigation of PRG2's biological significance.<br />
</think></p>
<h1 id="comprehensive-functional-annotation-of-the-prg2-gene-molecular-structure-cellular-localization-and-biological-functions">Comprehensive Functional Annotation of the PRG2 Gene: Molecular Structure, Cellular Localization, and Biological Functions</h1>
<p>The PRG2 gene (protein coding gene located on chromosome 11q12.1) encodes proteoglycan 2, also known as eosinophil major basic protein (MBP), which represents one of the most abundant and potent effector molecules produced by eosinophils[1][7][10]. This 117-amino acid protein serves as the predominant constituent of the crystalline core within eosinophil-specific granules and is subject to precise transcriptional and post-translational regulation to ensure safe storage while maintaining immediate availability for rapid cytotoxic deployment upon immune challenge[1][3][28]. PRG2 functions as a multifaceted molecular weapon in immune defense, exhibiting potent antimicrobial activity against gram-positive and gram-negative bacteria as well as fungi, while simultaneously orchestrating complex immunomodulatory effects through direct interactions with basophils, mast cells, and respiratory epithelial cells[1][7][20][22]. Beyond its classical roles in allergic inflammation and parasitic defense, emerging evidence suggests PRG2 may serve as a biomarker for certain hematologic disorders and possibly exert tumor-suppressive activities in specific disease contexts[3][55]. This comprehensive report synthesizes current molecular, biochemical, and cellular biological knowledge regarding PRG2, with particular emphasis on its structural features, subcellular compartmentalization, primary enzymatic and immunological functions, and integration into broader physiological and pathological processes.</p>
<h2 id="molecular-nomenclature-gene-organization-and-protein-identity">Molecular Nomenclature, Gene Organization, and Protein Identity</h2>
<p>The PRG2 gene has been assigned multiple identifiers across biological databases, including HGNC identifier 9362, NCBI Gene ID 5553, and Ensembl gene ID ENSG00000186652[1][10]. The protein product carries the UniProtKB/Swiss-Prot accession number P13727 and is commonly referred to by several synonyms reflecting its discovery and functional characterization history: bone marrow proteoglycan (BMPG), eosinophil granule major basic protein (EMBP), and natural killer cell activator[1][9]. The gene is located on the long arm of chromosome 11 (11q12.1) and spans approximately 4.9 kilobases of genomic DNA, encompassing six exons that generate the mature 222-amino acid protein following removal of the signal peptide and proteolytic processing of the prosequence[1][38]. The PRG2 gene produces alternatively spliced transcript variants that encode different isoforms, providing molecular diversity that may contribute to tissue-specific functions[1][50]. The predominant form synthesized during eosinophil differentiation is the proform (proMBP or proform of eosinophil major basic protein), consisting of an acidic N-terminal propiece comprising residues 1-106 connected through disulfide bonds to the highly cationic mature MBP domain (residues 107-222)[35][56]. The pro-domain serves a critical protective function during intracellular trafficking and storage, neutralizing the extreme basicity of the mature MBP and preventing accidental cytotoxic activation within the cell[35][56].</p>
<p>The gene exists as part of a small proteoglycan family, with PRG3 (also called eosinophil major basic protein 2 or MBP-2) representing an important paralog that shares approximately 73% amino acid sequence identity with PRG2 and exhibits similar functional properties including cytotoxic and immunomodulatory activities[52][40]. The structural similarity between PRG2 and PRG3 suggests they may have evolved from a common ancestral gene through duplication events, though their distinct tissue distribution and regulatory mechanisms indicate functional specialization[52]. In contrast to PRG3, PRG2 is predominantly expressed in bone marrow and placenta at the highest levels, with lower expression detected in a variety of tissues including kidney, myometrium, endometrium, ovaries, breast, prostate, and colon, suggesting regulated developmental and tissue-specific expression patterns[1][9][41].</p>
<h2 id="structural-organization-and-molecular-architecture">Structural Organization and Molecular Architecture</h2>
<p>PRG2/MBP possesses a unique structural fold categorized as a C-type lectin-like domain (CTLD), despite lacking the characteristic calcium-binding and carbohydrate-recognition properties of classical C-type lectins[7][30][56]. The protein architecture consists of two Œ±-helices and seven Œ≤-strands organized into three anti-parallel Œ≤-sheet arrays, with two disulfide bonds (Cys125-Cys220 and Cys197-Cys212) stabilizing local conformations by connecting the Œ±1 helix to Œ≤7 strand and anchoring the Œ≤6-Loop6-Œ≤7 region[56]. Crystallographic studies of granule-associated MBP-1 (gMBP-1) resolved at high resolution reveal a highly positive molecular surface, consistent with the protein's extreme basicity arising from its exceptionally high content of arginine and lysine residues (approximately 21% of amino acids)[56]. This cationic character is central to MBP's mechanism of action, enabling electrostatic interactions with anionic cellular membranes and enabling rapid membrane disruption following secretion.</p>
<p>Unlike canonical C-type lectins that recognize carbohydrates through a conserved canonical calcium-binding pocket, PRG2 instead recognizes heparan sulfate proteoglycans (HSPGs) through discrete surface-exposed residues that mediate specific protein-ligand interactions[7][56]. The downward-pointing loop configuration characteristic of the CTL fold in MBP is stabilized through aromatic stacking interactions involving tryptophan (Trp185) and proline (Pro190) residues, which engage in hydrophobic interactions with neighboring molecules during crystalline core formation[56]. This architectural feature is remarkably conserved across eosinophil MBP-1 homologues in higher primates, suggesting strong evolutionary pressure to maintain this specific structural arrangement, likely reflecting its functional importance for both storage and activation mechanisms.</p>
<p>The proform of PRG2 (proMBP) adds complexity to the structural organization through three intramolecular disulfide bonds linking the acidic propiece to the cationic MBP domain[35]. These disulfide linkages (Cys51-Cys169, Cys89-Cys128, and Cys104-Cys107) are thermodynamically stable in the oxidizing extracellular environment but are subject to controlled reduction through enzymatic and redox-sensitive mechanisms that regulate transition from the inactive proform to the toxic mature form[25][35]. The propiece itself contributes a high density of negatively charged acidic residues (glutamate and aspartate), providing electrostatic neutralization of the positive charges on the mature MBP domain and rendering proMBP physiologically inert and unsuitable for membrane disruption[25][35]. This elegant structural design ensures that the inherent toxicity of mature MBP is sequestered until appropriate biological signals trigger its liberation through proteolytic cleavage or redox-dependent disulfide reduction.</p>
<h2 id="cellular-localization-and-intracellular-compartmentalization">Cellular Localization and Intracellular Compartmentalization</h2>
<p>PRG2 demonstrates a highly specialized subcellular localization pattern reflecting its unique biology as an eosinophil-specific granule protein. During eosinophil differentiation, PRG2 synthesis occurs on ribosomes associated with the endoplasmic reticulum (ER), where the nascent polypeptide chain is directed to the ER lumen through an N-terminal signal peptide, leading to synthesis of the proform[1][9]. Following removal of the signal peptide by signal peptidase during translocation, proMBP transits from the ER through the Golgi apparatus in vesicular carriers, eventually accumulating within the specialized secretory granules characteristic of mature eosinophils[3][15]. Within these secretory granules, proMBP is packaged into the crystalloid core‚Äîan extraordinarily ordered nanocrystalline structure formed through precise intermolecular stacking interactions that occur exclusively following proteolytic removal of the propiece[25][28][56].</p>
<p>The organization into nanocrystalline cores appears to be a fundamental requirement for eosinophil viability, as studies employing targeted ablation of core cationic proteins (either EPX or MBP) result in selective loss of eosinophil lineage-committed progenitors and prevent normal eosinophil differentiation[3][15]. This remarkable observation suggests that the crystalline organization itself is essential for surviving the cytotoxic potential of these proteins and protecting the developing cell from self-inflicted damage. The crystalline arrangement achieves this through subtle conformational locking of the protein monomers that restrains their intrinsic membrane-disrupting potential until appropriate activation signals trigger crystal disassembly.</p>
<p>In placental tissues, proMBP localizes to the X cells of the syncytiotrophoblast septa and anchoring villi, where it exists in circulating levels in pregnancy serum[1][9][35]. The precise physiological function of proMBP in pregnancy remains incompletely understood, though its association with pregnancy-associated plasma protein A (PAPPA) and its regulatory effects on insulin-like growth factor bioavailability suggest roles in placental growth factor physiology and fetal development[3][21][35].</p>
<h2 id="storage-mechanisms-and-regulated-activation">Storage Mechanisms and Regulated Activation</h2>
<p>The storage of PRG2/MBP within eosinophil granules represents one of biology's most elegant solutions to the problem of safely housing a broadly toxic protein until the moment of deployment. The crystalline core packaging mechanism fundamentally alters the conformational state and biological activity of MBP-1, rendering intact nanocrystalline cores completely inert in bacterial killing assays despite the inherent toxicity of the monomeric protein[28]. This inactivation is achieved through specific intermolecular interactions occurring along crystallographic axes that stabilize conformations incompatible with membrane disruption. When crystalline cores are exposed to acidic pH conditions (pH 3.0), which occur during eosinophil granule acidification upon activation, the nanocrystals undergo controlled disassembly, liberating monomeric MBP-1 that rapidly undergoes amyloidogenic aggregation at neutral pH, ultimately generating the toxic oligomeric or fibrillar assemblies responsible for antimicrobial and immunomodulatory activities[28].</p>
<p>This pH-dependent activation mechanism represents a sophisticated two-stage control system ensuring that antimicrobial activity is reserved exclusively for extracellular environments where activated eosinophils encounter pathogens. The granule acidification below pH 4.0 that occurs upon immune stimulation through Fc receptors, chemokine receptors, or complement activation provides the biological trigger for this transformation[3][15][28]. Following granule acidification, eosinophils employ two complementary secretion pathways: classical exocytotic degranulation involving fusion of entire granules with the plasma membrane, and the more refined piecemeal degranulation (PMD) pathway that mobilizes specific granule constituents into small secretory vesicles for targeted delivery[15][18].</p>
<p>The piecemeal degranulation pathway demonstrates remarkable selectivity in transporting individual granule proteins, with MBP-1-containing vesicles trafficked through the cytoplasm in close association with the granule membrane, enabling regulated release of MBP-1 while leaving other granule components intact[15][18][33]. This selective trafficking mechanism depends critically upon receptor-mediated recognition of specific proteins within the granule lumen, with evidence indicating that cytokine-specific secretion is mediated through recognition by their cognate receptors localized to granule and secretory vesicle membranes[18]. The mobilization of MBP-1 into secretory vesicles occurs through budding from membrano-vesicular networks within the granule, producing tubular carriers and pleiomorphic vesicles that traverse the cytoplasm before docking and fusing with the plasma membrane[15][18][33].</p>
<h2 id="primary-biological-functions-cytotoxic-and-antimicrobial-properties">Primary Biological Functions: Cytotoxic and Antimicrobial Properties</h2>
<p>PRG2/MBP exerts potent antimicrobial activity through a fundamentally different mechanism from most traditional antimicrobial peptides, operating as a broad-spectrum toxin rather than a sequence-specific pathogen recognition molecule. The protein is directly toxic to a wide spectrum of targets including gram-positive bacteria, gram-negative bacteria, fungi, parasitic helminths, and even mammalian cells in vitro, reflecting its non-specific membrane-disrupting mechanism[1][7][20][22]. The peptide contains specific regions displaying particularly potent antimicrobial activity against gram-positive and gram-negative bacteria as well as fungi, though the molecular basis for any differential selectivity among these organisms remains incompletely characterized[1][20].</p>
<p>The cytotoxic mechanism involves initial formation of ion-selective pores in target cell membranes through insertion of oligomeric MBP-1 assemblies, followed by progression to non-selective membrane fragmentation as amyloid fibrils form on the membrane surface[28][31]. This two-step process bears mechanistic similarity to membrane disruption by amyloid-beta in neurodegeneration, suggesting that amyloidogenic aggregation may represent a general mechanism by which cationic antimicrobial peptides achieve their cytotoxic effects[28][31][34]. The formation of these structures depends upon the protein's extreme basicity, which enables electrostatic interactions with anionic phospholipid head groups and anionic polysaccharides on bacterial cell walls. The initial pore formation steps can be partially blocked by zinc ions, implicating specific histidine residues in the pore-forming mechanism, though the detailed structural basis remains to be fully elucidated[28].</p>
<p>Against parasitic helminths, MBP appears particularly effective, consistent with its evolutionary role in antiparasitic defense during helminth infection[1][36]. The protein acts as both a direct helminthotoxin through membrane disruption and an indirect effector through recruitment and activation of immune cells. The broad-spectrum nature of MBP toxicity reflects its lack of reliance on specific receptors or pathogen-associated molecular patterns, instead exploiting the fundamental biophysical incompatibility between a highly cationic peptide and the anionic lipid bilayers present on all cell membranes. This makes MBP immune to evasion strategies commonly employed against pattern recognition receptors, though it also requires careful containment within the eosinophil to prevent autotoxicity.</p>
<h2 id="immunomodulatory-functions-and-cross-talk-with-mast-cells-and-basophils">Immunomodulatory Functions and Cross-talk with Mast Cells and Basophils</h2>
<p>Beyond direct antimicrobial toxicity, PRG2/MBP serves critical immunomodulatory functions through diverse interactions with resident immune cells, particularly basophils and mast cells. MBP directly triggers non-cytolytic histamine release from purified human basophils through a mechanism that is IgE-independent and fundamentally distinct from classical IgE-mediated degranulation[11][37][40]. This basophil activation occurs with kinetics and potency characteristics similar to activation by other polycations such as poly-L-arginine, though MBP proves somewhat less potent than similarly-sized polycationic molecules[11][37]. The mechanism underlying MBP-induced histamine release involves electrostatic interactions between the highly cationic protein and anionic molecular targets on the basophil surface, likely involving plasma membrane proteoglycans or other anionic molecules, rather than a classical ligand-receptor interaction[11][37][40].</p>
<p>Critically, reduction and alkylation of MBP, treatments that modify cysteine residues within the protein, substantially diminish both the potency and efficacy of histamine release from human basophils, indicating that the native cysteine-containing disulfide structures are essential for optimal basophil activation[11][37]. This surprising dependence of an activity attributed to net charge on the native disulfide bonding pattern suggests more complex molecular interactions than simple electrostatic attraction, possibly involving specific conformational requirements for optimal engagement with basophil surface molecules.</p>
<p>MBP also activates rat peritoneal mast cells to release histamine in a manner characteristic of polycations, though the relative potency differs from basophil activation, and eosinophil cationic protein (ECP) shows distinct activity profiles in these two cell types[40]. This differential response reflects underlying differences in basophil and mast cell receptor expression and signaling mechanisms, suggesting that MBP engages distinct surface molecules on the two cell types or that downstream signaling diverges following initial engagement.</p>
<p>The physiological significance of MBP-induced basophil and mast cell histamine release lies in its role in amplifying allergic inflammation through the bidirectional basophil/mast cell-eosinophil regulatory axis[11][37]. Eosinophil-derived MBP released during eosinophilic inflammation stimulates mast cells and basophils to release histamine, which itself promotes eosinophil recruitment through histamine H4 receptor activation, thereby establishing a positive feedback loop that amplifies allergic responses[8]. This mechanism represents a critical pathogenic pathway in allergic diseases and may explain the often-dramatic worsening of allergic symptoms in conditions characterized by eosinophilic inflammation.</p>
<h2 id="activation-of-neutrophils-and-integration-into-innate-immune-signaling">Activation of Neutrophils and Integration into Innate Immune Signaling</h2>
<p>PRG2/MBP functions as a potent stimulus for neutrophil activation, triggering multiple effector functions including superoxide production, degranulation, and interleukin-8 (IL-8) production[19][20]. The molecular mechanism of neutrophil activation by MBP involves a Src kinase-dependent pathway that activates class IA phosphoinositide 3-kinase (PI3K) through tyrosine phosphorylation of the p85 regulatory subunit, leading to recruitment to the neutrophil plasma membrane[19]. PI3K activation generates phosphatidylinositol 3,4,5-trisphosphate (PIP3) at the membrane, which recruits proteins containing pleckstrin homology domains including Akt and the atypical protein kinase C zeta (PKCŒ∂). Akt phosphorylation at both Ser473 and Thr308 confirms that MBP stimulates full activation of this canonical survival kinase through a PI3K-dependent mechanism[19]. Notably, inhibition of PI3K activity blocks MBP-stimulated superoxide production but does not prevent degranulation or IL-8 production, indicating that these latter functions employ distinct signaling pathways not requiring PI3K.</p>
<p>PKCŒ∂ activation represents a critical downstream effector of MBP-stimulated superoxide production, as PKCŒ∂ phosphorylation at Thr410 occurs with kinetics paralleling PI3K p85 recruitment and Akt activation, and inhibition of PKCŒ∂ activity substantially reduces superoxide generation[19]. The phosphorylated PKCŒ∂ likely regulates the assembly or activation of the NADPH oxidase complex responsible for generating the respiratory burst in activated neutrophils. This signaling pathway represents a Src-PI3K-Akt-PKCŒ∂ cascade, providing a mechanistic explanation for how a cationic peptide engages surface molecules to trigger complex intracellular signaling events leading to coordinated activation of the antimicrobial oxidative burst.</p>
<h2 id="protein-protein-interactions-and-regulation-of-growth-factor-biology">Protein-Protein Interactions and Regulation of Growth Factor Biology</h2>
<p>A major functional role for PRG2 emerges from its interactions with pregnancy-associated plasma protein A (PAPPA), a metzincin superfamily metalloproteinase that mediates insulin-like growth factor (IGF) bioavailability through proteolytic cleavage of IGF-binding protein 4 (IGFBP-4)[3][12][24][35]. The proform of PRG2 (proMBP) forms specific covalent complexes with PAPPA through disulfide bonding involving multiple cysteine residues on both proteins, and these complexes serve as potent inhibitors of PAPPA proteolytic activity[3][12][24][35]. The formation of the PAPPA/proMBP complex involves a complex series of disulfide exchange reactions: the proMBP disulfide bond Cys51-Cys169 undergoes reduction and reformation as the first interchain disulfide (Cys169-Cys652 of PAPPA), followed by disruption of the proMBP disulfide Cys89-Cys128 to form a second interchain disulfide (Cys51-Cys381 of PAPPA)[35]. ProMBP then dimerizes through formation of interchain disulfides (Cys104-Cys104 and Cys107-Cys107) between two Cys104-Cys107 intrachain disulfides, creating a highly ordered complex architecture[35].</p>
<p>The PAPPA/proMBP complex does not bind to heparan sulfate proteoglycans on the cell surface, unlike uncomplexed PAPPA which localizes to the surface through interactions of its complement control protein modules 3 and 4 with heparan sulfate chains[35]. However, the surface-binding capacity can be regained following heparinase treatment of the complex, indicating that the proMBP GAG chain can compete with the PAPPA HSPG receptor for binding following disruption of the covalent complex[35]. The proMBP GAG does not mediate initial recognition of PAPPA; rather, recognition depends on protein-protein interactions involving specific regions of the MBP domain (Loop 2 and the loop between Strand 2 and Helix 2), with Cys169 positioned in the binding interface[35]. Complex formation causes conformational changes that reduce surface binding affinity, providing a mechanism for releasing PAPPA from the cell surface and regulating the spatial availability of IGF-bioavailable IGFBP-4 cleavage products.</p>
<p>This regulatory interaction holds significant physiological implications for placental development and fetal growth, as studies have demonstrated that increased circulating IGFBP-4 in early pregnancy correlates with development of fetal growth restriction, while increased PAPPA levels correlate with normal fetal growth[21][24]. The relative balance between PAPPA and proMBP activities thus influences IGF availability for placental and fetal growth promotion, suggesting that dysregulation of this interaction may contribute to adverse pregnancy outcomes[3][21][24]. The appearance of proMBP in pregnancy serum at high concentrations, complexed with PAPPA and other proteins including angiotensinogen and C3dg, indicates this system is mobilized during reproduction, though the precise maternal physiological benefits of this mobilization remain incompletely understood[1][35][41].</p>
<h2 id="transcriptional-regulation-and-developmental-gene-expression">Transcriptional Regulation and Developmental Gene Expression</h2>
<p>The PRG2 gene is subject to precise transcriptional control during eosinophil differentiation through a complex combinatorial network of lineage-specific transcription factors. Studies employing nuclear extracts from eosinophil-committed cell lines and in vitro transcription assays have identified a synergistic activation mechanism involving GATA-1 and PU.1, two transcription factors essential for myeloid and eosinophil development[3][43][46]. The eosinophil-specific P2 promoter of the PRG2 gene contains consensus binding sites for GATA-1, C/EBP family proteins, and PU.1 that all contribute to transcriptional regulation[43][46]. GATA-1 alone produces basal transactivation of the MBP promoter, but low levels of PU.1 in combination with optimal GATA-1 levels generate synergistic transactivation substantially exceeding the additive effects of the individual factors[43][46].</p>
<p>This cooperative GATA-1/PU.1 interaction is critically regulated by the CCAAT enhancer binding protein epsilon (C/EBPŒµ) family of proteins[3][43][46]. Certain isoforms of C/EBPŒµ, particularly the C/EBPŒµ(27) isoform, function as potent repressors of both GATA-1 activity and the GATA-1/PU.1 synergy, thereby establishing a tightly controlled program for MBP expression in developing eosinophils[3][43][46]. In vitro mutational analysis of the MBP-P2 promoter has demonstrated that both the GATA-1/PU.1 synergy and C/EBPŒµ(27) repressor activity are mediated through protein-protein interactions occurring at the C/EBP and/or GATA-binding sites, rather than through direct DNA binding by PU.1 in these regions[43]. Co-immunoprecipitation studies using lysates from eosinophil myelocyte cell lines confirm that C/EBPŒµ isoforms physically interact in vivo with both PU.1 and GATA-1, demonstrating that functional interactions among these factors occur in native eosinophil progenitors[43].</p>
<p>The broader context of eosinophil lineage commitment reveals that GATA-1 is absolutely required for eosinophil development, as mice bearing mutations in the Gata1 promoter that reduce Gata1 expression by approximately 75% lack eosinophils[46]. Furthermore, eosinophil potential is restricted to GATA-1-positive myeloid progenitors, and human hematopoietic progenitors receiving ectopic GATA-1 expression alone are sufficient to undergo eosinophil differentiation[46]. The eosinophil-lineage priming process involves complex interactions between GATA factors, C/EBP family members, and the GATA co-factor FOG-1 (Friend of GATA-1), with FOG-1 normally acting as a repressor of eosinophil potential[46]. PU.1 antagonizes GATA-1 expression in multipotent progenitors but appears less critical than previously believed for later stages of eosinophil commitment, as PU.1-deficient fetal liver cells retain expression of both eosinophil peroxidase and MBP[46].</p>
<p>IRF8 (interferon regulatory factor 8) provides early driving force for eosinophil fate commitment through direct transcriptional activation of Gata1, and IRF8-deficient mice show reductions in both eosinophil progenitors and Gata1 expression in these cells[46]. The precise temporal sequence of transcription factor expression and the specific protein-DNA and protein-protein interactions governing MBP gene transcription remain subjects of ongoing investigation, particularly through emerging techniques enabling analysis of chromatin accessibility and transcription factor occupancy during eosinophil development.</p>
<h2 id="interaction-with-respiratory-pathogens-and-epithelial-cell-dysfunction">Interaction with Respiratory Pathogens and Epithelial Cell Dysfunction</h2>
<p>PRG2/MBP plays an important pathogenic role in allergic airway disease through its capacity to interact directly with viral pathogens and synergize with viral pathogen-associated molecular patterns to trigger epithelial cell damage. Studies examining respiratory syncytial virus (RSV) infection have demonstrated that MBP synergizes with viral pathogen signals to provoke airway epithelial cell death and release of pro-inflammatory cytokines[3][20][26]. The mechanism underlying this synergy likely involves simultaneous engagement of viral pattern recognition pathways and direct membrane disruption by MBP, resulting in amplified epithelial cell damage beyond that caused by either stimulus alone. This MBP-virus synergy contributes to the immunopathology of RSV bronchiolitis, where eosinophilic infiltration of airways correlates with more severe disease, and elevated MBP levels are detected in respiratory secretions of patients with acute viral bronchiolitis[3][20].</p>
<p>Beyond respiratory pathogens, MBP contributes to local tissue damage and epithelial barrier dysfunction in various conditions characterized by eosinophilic inflammation. In eosinophilic esophagitis, a disorder of increasing prevalence characterized by dense eosinophilic infiltration of the esophageal mucosa, MBP-containing granule products are directly implicated in epithelial cell exfoliation and damage[3][15][20][23]. Similar mechanisms operate in other eosinophil-associated inflammatory conditions including atopic dermatitis (where keratinocyte damage occurs through direct MBP effects), eosinophilic myositis (tissue-infiltrating eosinophil-derived MBP damages muscle fibers), atopic cataracts (lens epithelial cell damage from eosinophil products), and chronic rhinosinusitis (nasal epithelial damage and polyp formation)[3][20][23]. In respiratory epithelia particularly, MBP directly damages epithelial cells through multiple mechanisms including direct membrane disruption, interference with tight junction protein expression, and induction of epithelial cell apoptosis or necroptosis.</p>
<p>The epithelial barrier dysfunction occurring in allergic diseases involves MBP-mediated disruption of tight junction organization, reduced expression of critical tight junction proteins including zonula occludens-1 (ZO-1) and occludin, and physical separation of adjacent epithelial cells[23]. These structural changes increase epithelial permeability, facilitating increased penetration of allergens and pathogens across epithelial barriers, thereby amplifying allergic inflammation in a feedforward manner. MBP also induces histamine release from epithelial mast cells, further promoting barrier dysfunction through histamine-receptor signaling that modulates tight junction integrity.</p>
<h2 id="heparan-sulfate-proteoglycan-binding-and-signal-modulation">Heparan Sulfate Proteoglycan Binding and Signal Modulation</h2>
<p>PRG2/MBP recognizes heparan sulfate proteoglycans (HSPGs) through discrete surface-exposed residues that appear to represent an evolutionarily conserved feature of the C-type lectin-like fold[7][30][56]. Unlike classical C-type lectins that employ a canonical carbohydrate-binding pocket requiring coordinated calcium, MBP binding to HSPGs occurs through a distinct structural mechanism involving aromatic amino acid residues positioned in the characteristic downward-pointing loop configuration of the CTL domain[56]. The functional significance of HSPG binding likely involves positioning MBP at cell surfaces where HSPGs are abundant, potentially enhancing local concentrations and enabling more efficient cell targeting. Moreover, HSPG binding may direct MBP toward specific cellular compartments or membrane microdomains containing target proteins or receptors involved in downstream signaling.</p>
<p>The strategic positioning of MBP through HSPG binding in inflammatory tissues suggests its role as an intercellular signal modulator in inflammatory settings[3][20]. Rather than operating solely as a diffusible toxin, membrane-bound MBP pools at HSPG-enriched sites on epithelial cells and infiltrating immune cells may trigger local signaling cascades through proximity effects and enhanced local concentration. This mechanism would allow eosinophils to establish localized zones of MBP-dependent cellular activation while minimizing systemic toxicity through compartmentalization.</p>
<h2 id="amyloidogenic-aggregation-and-toxicity-mechanisms">Amyloidogenic Aggregation and Toxicity Mechanisms</h2>
<p>Recent structural studies employing X-ray free electron laser (XFEL) radiation on nanocrystalline MBP-1 within intact eosinophil granules have revealed that the storage and activation of MBP involves a remarkable transition from ordered crystalline states to amyloidogenic fibrillar assemblies[25][28][34]. The nanocrystalline cores lock MBP-1 in a non-toxic conformation through specific intermolecular interactions occurring along defined crystallographic axes, particularly the two-fold screw axis along the crystallographic c-axis[28][56]. The packing observed in natural granule cores differs substantially from crystals grown in vitro through re-crystallization from acid-solubilized protein, likely reflecting differences in the chemical microenvironment in vivo including pH, redox conditions, and ionic strength[28].</p>
<p>Upon granule acidification below pH 4.0 during eosinophil activation, the ordered crystalline lattice undergoes controlled disassembly, liberating monomeric MBP-1 that rapidly equilibrates to neutral pH upon secretion[28]. At neutral pH, the released MBP-1 undergoes amyloidogenic aggregation, generating toxic oligomeric and fibrillar assemblies that directly disrupt biological membranes through a two-step mechanism[28][31][34]. The initial step involves formation of ion-selective pores through insertion of oligomeric MBP-1 assemblies into target membranes, recapitulating channel formation detected in earlier electrophysiological studies[28][31]. The second step involves amyloid fibril elongation directly on the membrane surface, causing non-selective physical disruption through a detergent-like mechanism that fragments the lipid bilayer[28][31].</p>
<p>The aggregation-prone segments identified within the MBP-1 sequence, including the 26-30 steric zipper, likely facilitate amyloid formation and may be conserved across eosinophil cationic proteins including eosinophil cationic protein (ECP)[28]. The parallels between MBP amyloidogenic mechanisms and Alzheimer amyloid-beta toxicity suggest that amyloidogenic aggregation represents a conserved mechanism by which cationic antimicrobial peptides achieve biological activity, possibly reflecting evolutionary pressure to employ irreversible, hard-to-reverse mechanisms for antimicrobial defense. The functional evidence that intact MBP-1 nanocrystalline cores fail to elicit significant bacterial killing while cores treated at pH 3.0 rescue toxicity provides compelling evidence that the crystallization process fundamentally alters protein conformation and immunoreactivity in ways that prevent membrane disruption.</p>
<h2 id="disease-associations-and-potential-tumor-suppressor-functions">Disease Associations and Potential Tumor Suppressor Functions</h2>
<p>PRG2 gene alterations have been associated with several human diseases. The most direct associations include <strong>dermatographia</strong> (a condition characterized by exaggerated skin reactivity and histamine-mediated whealing responses) and <strong>hypereosinophilic syndrome</strong> (a disorder involving sustained overproduction of eosinophils with multi-organ involvement)[1][49]. These disease associations likely reflect dysregulation of normal PRG2 expression or function leading to excessive or inappropriate eosinophil accumulation and MBP release.</p>
<p>Emerging evidence suggests PRG2 may function as a tumor suppressor gene in certain hematologic malignancies, particularly in chronic myeloid leukemia (CML) cells resistant to imatinib tyrosine kinase inhibitor therapy[55]. Studies employing demethylation with 5-azacytidine found that forced PRG2 expression in imatinib-resistant K562 cells is associated with STAT3 inactivation, restoration of imatinib sensitivity, and enhanced apoptosis[55]. The methylation status of the PRG2 gene inversely correlates with expression levels and imatinib sensitivity, indicating that epigenetic silencing of PRG2 through DNA hypermethylation contributes to the resistant phenotype[55]. This tumor suppressor function likely involves PRG2-mediated inhibition of the JAK/STAT3 signaling pathway, as re-expression studies demonstrate STAT3 inactivation accompanying PRG2 upregulation[55]. The molecular basis for PRG2-mediated STAT3 suppression remains to be fully elucidated, though possibilities include direct protein-protein interactions, regulation of STAT3-inhibitory proteins such as SOCS-1 and SOCS-3, or indirect effects through alterations in cellular redox status affecting kinase and phosphatase activities.</p>
<h2 id="alternative-splicing-and-protein-diversity">Alternative Splicing and Protein Diversity</h2>
<p>The PRG2 gene generates multiple transcript variants through alternative splicing mechanisms that produce isoforms with potentially distinct functions[1][50]. Alternative splicing represents a major mechanism for expanding proteome complexity in eukaryotes, with individual protein-coding genes producing an average of 5.4 different mRNA species through various splicing patterns[50]. Seven basic types of alternative splicing have been characterized, including exon skipping, alternative 5' and 3' splice sites, mutually exclusive exons, intron retention, alternative promoters, and alternative polyadenylation[50]. The regulation of alternative splicing depends on the intrinsic strength of splice sites, the concentration and composition of splicing regulatory factors (including SR proteins and heterogeneous nuclear ribonucleoproteins), chromatin modifications, and RNA secondary structure elements[50].</p>
<p>The availability of multiple PRG2 isoforms suggests tissue-specific specialization, with different isoforms potentially exhibiting distinct subcellular localizations, stability, or functional properties[1]. The splicing pattern is likely regulated by eosinophil-specific factors that differ from those present in other cell types, contributing to the cell-type specificity of eosinophil protein expression. Understanding the functional significance of individual PRG2 splice variants represents an important frontier in eosinophil biology and may reveal novel therapeutic targets for modulating eosinophil-mediated inflammation.</p>
<h2 id="conclusion">Conclusion</h2>
<p>The PRG2 gene encodes a structurally and functionally sophisticated multi-domain protein that integrates antimicrobial, immunomodulatory, and growth-factor regulatory functions within a single 222-amino acid polypeptide. As the predominant constituent of eosinophil granule crystalline cores, PRG2/MBP represents an evolutionary solution to the challenge of storing an inherently toxic protein in a safe, inert state while maintaining rapid availability for immediate deployment upon immune challenge. The protein's extreme cationic charge density and C-type lectin-like structural fold enable broad-spectrum antimicrobial toxicity through non-specific membrane disruption mechanisms, while simultaneously allowing selective immunomodulatory engagement with basophils, mast cells, and neutrophils through more sophisticated signaling pathways. The subcellular compartmentalization of PRG2 in secretory granules, its protection through encapsulation in nanocrystalline cores, and its regulated mobilization through piecemeal degranulation mechanisms exemplify how the immune system achieves safety and specificity in employing inherently dangerous effector molecules. The emerging tumor suppressor functions and broader physiological roles of PRG2 in placental development through growth factor regulation suggest that this protein likely possesses additional uncharacterized biological activities. Future investigations employing structural biology, cellular biology, and tissue-specific knockout approaches should illuminate the complete repertoire of PRG2 functions and identify precise therapeutic opportunities for modulating eosinophil-mediated inflammation in allergic and other immune-mediated diseases.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2</li>
<li>https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.984655/full</li>
<li>https://maayanlab.cloud/Harmonizome/gene/PRG2</li>
<li>https://www.uniprot.org/uniprotkb/P13727/entry</li>
<li>https://www.ncbi.nlm.nih.gov/gene/5553</li>
<li>https://febs.onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.1987.tb11172.x</li>
<li>https://en.wikipedia.org/wiki/Major_basic_protein</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC1574117/</li>
<li>https://www.affbiotech.com/goods-5794-DF6992-PRG2_Antibody.html</li>
<li>https://pubmed.ncbi.nlm.nih.gov/6854212/</li>
<li>https://thebiogrid.org/interaction/303046/pappa-prg2.html</li>
<li>https://www.ncbi.nlm.nih.gov/books/NBK1943/</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=5553</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5783317/</li>
<li>https://www.ncbi.nlm.nih.gov/books/NBK579916/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3427618/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/14500673/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/22689691/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9030405/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/10077652/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11483036/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7258638/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3322459/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4904734/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC137037/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3443794/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11394122/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6332049/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3709793/</li>
<li>https://academic.oup.com/biolreprod/article/84/6/1077/2530375</li>
<li>https://pubmed.ncbi.nlm.nih.gov/36890022/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2187055/</li>
<li>https://www.ncbi.nlm.nih.gov/gtr/genes/5553/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/30507713/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/6206154/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11855017/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/12202480/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10885618/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2911633/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7388079/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12531897/</li>
<li>https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2020.00231/full</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8951537/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8530902/</li>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG3</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2613545/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2581549/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6103584/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9595336/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8355064/</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity Lite</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(PRG2-deep-research-perplexity-lite.md)</span>
                </div>
                <div class="vote-buttons" data-g="P13727" data-a="DOC: Deep Research Perplexity Lite" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-pro<br />
cached: false<br />
start_time: '2025-11-03T21:53:56.902433'<br />
end_time: '2025-11-03T21:54:10.406097'<br />
duration_seconds: 13.5<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: low<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 15</p>
<hr />
<h2 id="question">Question</h2>
<p>Research the PRG2 (P13727) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.</p>
<h2 id="output">Output</h2>
<p>The <strong>PRG2 gene (P13727)</strong> encodes <strong>eosinophil major basic protein (MBP)</strong>, a cytotoxic and immunomodulatory protein predominantly found in eosinophil granules, with key roles in immune defense, allergic inflammation, and tissue remodeling[1][3][9].</p>
<hr />
<h3 id="1-key-concepts-and-definitions">1. Key Concepts and Definitions</h3>
<ul>
<li><strong>Molecular Function:</strong>  </li>
<li><strong>Cytotoxin and helminthotoxin:</strong> MBP is toxic to helminths, bacteria, and mammalian cells, contributing to antiparasitic defense[1][3][9].</li>
<li><strong>Histamine release:</strong> MBP induces non-cytolytic histamine release from basophils and mast cells, promoting allergic responses[1][3][9].</li>
<li><strong>Carbohydrate and heparin binding:</strong> MBP binds heparan sulfate proteoglycans on cell surfaces, acting as an intercellular signal modulator in inflammation[1][3][4].</li>
<li>
<p><strong>Proteinase inhibitor:</strong> The proform of MBP inhibits pregnancy-associated plasma protein A (PAPPA)[1][3][4].</p>
</li>
<li>
<p><strong>Biological Processes:</strong>  </p>
</li>
<li><strong>Antiparasitic defense mechanisms</strong>  </li>
<li><strong>Immune hypersensitivity reactions</strong>  </li>
<li><strong>Negative regulation of macrophage cytokine production</strong>  </li>
<li>
<p><strong>Tissue damage and remodeling in allergic diseases (e.g., asthma, chronic rhinosinusitis, eosinophilic myositis)</strong>[1][2][3][4][12]</p>
</li>
<li>
<p><strong>Cellular Localization:</strong>  </p>
</li>
<li><strong>Granule core of eosinophils:</strong> MBP is the main constituent of eosinophil granules[1][3].</li>
<li><strong>Secreted protein:</strong> MBP is released extracellularly, especially during eosinophil activation[4][7].</li>
<li><strong>Detected in placenta and pregnancy serum:</strong> Exists as a complex with PAPPA, angiotensinogen (AGT), and C3dg[1][3].</li>
</ul>
<hr />
<h3 id="2-protein-domains">2. Protein Domains</h3>
<ul>
<li><strong>Lectin_C domain (PF00059):</strong><br />
  MBP has a fold similar to C-type lectins (sugar-binding proteins), but does not bind calcium or typical lectin carbohydrates; instead, it binds heparan sulfate proteoglycans[3][4][7].</li>
<li><strong>Signal region:</strong><br />
  Amino acids 1‚Äì16, indicating secretion[4][7].</li>
</ul>
<hr />
<h3 id="3-known-interactions">3. Known Interactions</h3>
<ul>
<li><strong>Protein complexes:</strong>  </li>
<li>MBP forms complexes with <strong>PAPPA</strong>, <strong>AGT</strong>, and <strong>C3dg</strong> in pregnancy serum[1][3].</li>
<li><strong>Cellular targets:</strong>  </li>
<li><strong>Basophils and mast cells:</strong> Induces histamine release[1][3][9].</li>
<li><strong>Neutrophils and macrophages:</strong> Activates these cells, contributing to inflammation[2][3].</li>
<li><strong>Respiratory epithelial cells:</strong> Synergizes with pathogens to provoke cell death and cytokine release[2].</li>
</ul>
<hr />
<h3 id="4-disease-associations">4. Disease Associations</h3>
<ul>
<li><strong>Dermatographia:</strong><br />
  Associated with hypersensitivity and skin reactions[1].</li>
<li><strong>Hypereosinophilic syndrome:</strong><br />
  Linked to excessive eosinophil activity and tissue damage[1].</li>
<li><strong>Allergic diseases:</strong><br />
  MBP is implicated in asthma, chronic rhinosinusitis, and other allergic conditions due to its role in epithelial damage and bronchospasm[1][2][3].</li>
<li><strong>Pregnancy-related disorders:</strong><br />
  Altered MBP levels and complexes in pregnancy serum may be relevant to placental function[1][3].</li>
<li><strong>Cancer:</strong><br />
  Emerging evidence suggests PRG2 may act as a tumor suppressor in certain hematologic malignancies, with overexpression linked to inactivation of STAT3 and increased drug sensitivity[2].</li>
</ul>
<hr />
<h3 id="5-recent-developments-and-latest-research-20232024">5. Recent Developments and Latest Research (2023‚Äì2024)</h3>
<ul>
<li><strong>Tumor suppressor role:</strong><br />
  Recent studies indicate PRG2 overexpression in imatinib-resistant chronic myeloproliferative cells leads to STAT3 inactivation and enhanced drug sensitivity, suggesting a potential tumor suppressor function[2].</li>
<li><strong>Biomarker potential:</strong><br />
  PRG2 expression and circulating proMBP levels are being investigated as biomarkers in hematologic disorders[2].</li>
<li><strong>Structural studies:</strong><br />
  Crystallographic structures of MBP have been determined, confirming its lectin-like fold and heparan sulfate binding specificity[3].</li>
</ul>
<hr />
<h3 id="6-statistics-and-data">6. Statistics and Data</h3>
<ul>
<li><strong>Protein length:</strong><br />
  222 amino acids[4][7].</li>
<li><strong>Molecular weight:</strong><br />
  25,205 Da[4][7].</li>
<li><strong>Theoretical pI:</strong><br />
  6.64[4][7].</li>
</ul>
<hr />
<h3 id="7-expert-opinions-and-authoritative-analysis">7. Expert Opinions and Authoritative Analysis</h3>
<ul>
<li><strong>GeneCards, UniProt, and NCBI</strong> consistently describe PRG2/MBP as a key effector in eosinophil-mediated immunity and allergic inflammation, with well-established cytotoxic and immunomodulatory functions[1][3][6][9][11].</li>
<li><strong>Recent research</strong> highlights its emerging roles in cancer biology and as a biomarker, expanding its relevance beyond classical allergic and parasitic contexts[2].</li>
</ul>
<hr />
<p><strong>URLs and Publication Dates:</strong><br />
- GeneCards (2024): https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2<br />
- Ma‚Äôayan Lab Harmonizome (2024): https://maayanlab.cloud/Harmonizome/gene/PRG2<br />
- Wikipedia (2024): https://en.wikipedia.org/wiki/Major_basic_protein<br />
- DrugBank (2024): https://go.drugbank.com/bio_entities/BE0002114<br />
- UniProt (2024): https://www.uniprot.org/uniprotkb/P13727/entry<br />
- NCBI Gene (2025): https://www.ncbi.nlm.nih.gov/gene/5553</p>
<p>If you need more details on specific protein structures, clinical studies, or recent publications, please specify the focus area.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG2</li>
<li>https://maayanlab.cloud/Harmonizome/gene/PRG2</li>
<li>https://en.wikipedia.org/wiki/Major_basic_protein</li>
<li>https://go.drugbank.com/bio_entities/BE0002114</li>
<li>https://www.reactome.org/content/schema/instance/browser/uniprot:P13727</li>
<li>https://www.ncbi.nlm.nih.gov/gene/5553</li>
<li>https://go.drugbank.com/polypeptides/P13727</li>
<li>https://geneglobe.qiagen.com/us/knowledge/gene/ENSG00000186652</li>
<li>https://www.uniprot.org/uniprotkb/P13727/entry</li>
<li>https://research.bioinformatics.udel.edu/pro/entry/PR:P13727/</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=5553</li>
<li>https://www.multisciences.net/target/prg2</li>
<li>https://glygen.org/protein/P13727</li>
<li>https://functionome.geneontology.org/gene/UniProtKB:P13727</li>
<li>https://www.promega.ca/findmygene/genedetail.aspx?ncbiid=5553</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: P13727
gene_symbol: PRG2
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &#39;Eosinophil major basic protein 1 (MBP-1), a highly cationic protein
  (~13.8 kDa, pI ~11.4) that is the predominant constituent of the crystalline core
  in eosinophil secondary granules. Synthesized as a 222-amino acid precursor with
  an acidic, heavily glycosylated prosegment (~9 kDa) that neutralizes the toxicity
  of the basic mature domain during biosynthesis. The prosegment contains N-linked,
  O-linked, and glycosaminoglycan chains (hence &#34;proteoglycan 2&#34;), raising precursor
  mass to 30-50 kDa. Upon maturation, the prosegment is proteolytically cleaved in
  the Golgi/secretory granule, yielding the active 117-residue MBP that is stored
  in paracrystalline arrays within granules. Structurally, MBP adopts a C-type lectin-like
  fold but lacks Ca2+-binding sites; instead presents a highly cationic surface for
  binding sulfated polysaccharides like heparin and heparan sulfate. Primary function:
  cytotoxic effector in antiparasitic defense - directly damages helminth larvae membranes
  and cuticles (experimental knockout mice show impaired killing of Strongyloides
  and filarial worms). Also exhibits broad antimicrobial activity against bacteria
  and fungi via membrane disruption. Immunomodulatory roles: triggers degranulation
  of mast cells and basophils (histamine release), activates neutrophils (superoxide
  production) and platelets. Toxic to host cells - causes epithelial damage and denudation
  in allergic diseases. In asthma, acts as allosteric antagonist of M2 muscarinic
  acetylcholine receptors on parasympathetic neurons, disabling inhibitory feedback
  and causing bronchospasm and airway hyperresponsiveness. Inhibits heparanase (first
  known endogenous heparanase inhibitor). In chronic settings, induces TGF-Œ≤ and MMP-1
  expression, promoting fibrosis and tissue remodeling. Dual biology: the proMBP form
  is abundantly expressed in placenta during pregnancy and secreted into maternal
  circulation, where it forms disulfide-linked 1:1 complexes with PAPP-A (pregnancy-associated
  plasma protein A), inhibiting this metalloprotease&#39;&#39;s cleavage of IGFBPs and thereby
  modulating IGF signaling for fetal growth. ProMBP also binds angiotensinogen and
  complement C3dg. The PAPP-A/proMBP complex is a clinical biomarker in first-trimester
  Down syndrome screening. ProMBP is non-toxic (acidic prosegment renders it inert),
  contrasting with the highly cytotoxic mature MBP released from eosinophils. MBP
  levels correlate with disease severity in asthma, eosinophilic esophagitis, and
  other eosinophil-driven conditions.&#39;
existing_annotations:
- term:
    id: GO:0002376
    label: immune system process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Electronic annotation for immune system process from UniProt keywords.
      MBP is central to eosinophil-mediated immunity.
    action: ACCEPT
    reason: Core biological process - MBP is key effector in antiparasitic and antimicrobial
      defense.
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: Extracellular region from UniProt subcellular location. MBP is released
      from eosinophils and acts extracellularly.
    action: ACCEPT
    reason: Core localization - MBP functions in extracellular space after degranulation.
- term:
    id: GO:0006955
    label: immune response
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Electronic annotation for immune response from InterPro domain. MBP kills
      parasites and microbes as part of innate immunity.
    action: ACCEPT
    reason: Core function in immune defense, experimentally validated in helminth
      killing.
- term:
    id: GO:0008201
    label: heparin binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Heparin binding from UniProt keywords. MBP strongly binds heparin and
      heparan sulfate via cationic surface.
    action: ACCEPT
    reason: Core molecular function - crystal structure shows heparin-binding site,
      physiologically relevant for tissue interactions.
- term:
    id: GO:0030133
    label: transport vesicle
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: Transport vesicle from UniProt subcellular location. MBP is in secretory
      granules.
    action: ACCEPT
    reason: Accurate - MBP is stored in eosinophil secondary granules (transport/secretory
      vesicles).
- term:
    id: GO:0030246
    label: carbohydrate binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Carbohydrate binding from UniProt keywords. MBP has C-type lectin-like
      fold and binds sulfated polysaccharides.
    action: ACCEPT
    reason: Structural feature - lectin-like fold binds sulfated carbohydrates.
- term:
    id: GO:0031410
    label: cytoplasmic vesicle
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Cytoplasmic vesicle from UniProt keywords. Same as transport vesicle
      - eosinophil granules.
    action: ACCEPT
    reason: Granules are cytoplasmic vesicles, accurate localization.
- term:
    id: GO:0042742
    label: defense response to bacterium
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Defense response to bacterium from UniProt keywords. MBP has direct antimicrobial
      activity against Gram+ and Gram- bacteria.
    action: ACCEPT
    reason: Experimentally supported - MBP and derived peptides kill bacteria via
      membrane disruption.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:12421832
  review: &amp;id001
    summary: Protein binding from PMID:7685339 (original PAPP-A/proMBP complex discovery).
    action: ACCEPT
    reason: Seminal paper demonstrating proMBP-PAPP-A disulfide bridge in pregnancy
      serum.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:7685339
  review: *id001
- term:
    id: GO:0002215
    label: defense response to nematode
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Defense response to nematode from Ensembl orthology. MBP is critical
      for killing helminth parasites.
    action: ACCEPT
    reason: Core antiparasitic function - knockout mice show impaired killing of Strongyloides
      and filarial worms.
- term:
    id: GO:0032693
    label: negative regulation of interleukin-10 production
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Negative regulation of IL-10 production from Ensembl orthology. May reflect
      immunomodulatory effects.
    action: KEEP_AS_NON_CORE
    reason: Pleiotropic immunomodulation, not direct core function of MBP.
- term:
    id: GO:0032753
    label: positive regulation of interleukin-4 production
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Positive regulation of IL-4 production from Ensembl orthology. Reflects
      role in Th2 allergic responses.
    action: KEEP_AS_NON_CORE
    reason: Downstream effect in allergic inflammation, not core molecular function.
- term:
    id: GO:0030021
    label: extracellular matrix structural constituent conferring compression resistance
  evidence_type: HDA
  original_reference_id: PMID:28344315
  review:
    summary: ECM structural constituent conferring compression resistance from PMID:28344315
      (myeloma bone marrow ECM proteomics).
    action: REMOVE
    reason: Over-annotation from high-throughput proteomics. MBP is not a structural
      ECM protein, likely contaminant from eosinophils in marrow.
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: HDA
  original_reference_id: PMID:28344315
  review: &amp;id002
    summary: Extracellular matrix from PMID:25037231 (proteomics).
    action: REMOVE
    reason: Same as above - not an ECM component.
- term:
    id: GO:0030021
    label: extracellular matrix structural constituent conferring compression resistance
  evidence_type: RCA
  original_reference_id: PMID:25037231
  review:
    summary: ECM structural constituent from PMID:25037231 (colon cancer ECM proteomics).
      Same as above.
    action: REMOVE
    reason: Over-annotation from proteomics. MBP may bind to ECM via heparan sulfate
      but is not a structural ECM component.
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: HDA
  original_reference_id: PMID:25037231
  review: *id002
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6800434
  review: &amp;id003
    summary: Extracellular region from PMID:8547309 (rat MBP cloning, showing secreted
      protein).
    action: ACCEPT
    reason: Confirmed secreted protein localization.
- term:
    id: GO:1904813
    label: ficolin-1-rich granule lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6800434
  review:
    summary: Ficolin-1-rich granule lumen from Reactome:R-HSA-6800434. Very specific
      granule type.
    action: KEEP_AS_NON_CORE
    reason: Too specific. MBP is in eosinophil granules, not ficolin-rich granules
      (neutrophil-specific). Likely annotation error.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  review:
    summary: Extracellular exosome from PMID:23533145 (prostatic secretion exosome
      proteomics).
    action: REMOVE
    reason: Over-annotation from high-throughput study. MBP not normally in exosomes,
      likely contamination.
- term:
    id: GO:0030246
    label: carbohydrate binding
  evidence_type: TAS
  original_reference_id: PMID:1565101
  review:
    summary: Carbohydrate binding with traceable author statement from PMID:1565101
      (original characterization).
    action: ACCEPT
    reason: Experimentally demonstrated carbohydrate binding activity.
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: PMID:8547309
  review: *id003
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt.
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: PMID:12421832
  title: Complex of pregnancy-associated plasma protein-A and the proform of eosinophil
    major basic protein. Disulfide structure and carbohydrate attachment.
  findings: []
- id: PMID:1565101
  title: &#39;Purification and cDNA cloning of a novel factor produced by a human T-cell
    hybridoma: sequence homology with animal lectins.&#39;
  findings: []
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
    secretions in urine.
  findings: []
- id: PMID:25037231
  title: Extracellular matrix signatures of human primary metastatic colon cancers
    and their metastases to liver.
  findings: []
- id: PMID:28344315
  title: Proteomic characterization of human multiple myeloma bone marrow extracellular
    matrix.
  findings: []
- id: PMID:7685339
  title: Circulating human pregnancy-associated plasma protein-A is disulfide-bridged
    to the proform of eosinophil major basic protein.
  findings: []
- id: PMID:8547309
  title: Cloning of cDNA for rat eosinophil major basic protein.
  findings: []
- id: Reactome:R-HSA-6800434
  title: Exocytosis of ficolin-rich granule lumen proteins
  findings: []
aliases:
- Eosinophil major basic protein 1
- MBP-1
- MBP
- BMPG
- Bone marrow proteoglycan
- Pregnancy-associated major basic protein
core_functions:
- molecular_function:
    id: GO:0008201
    label: heparin binding
  description: Binding sulfated polysaccharides (heparin, heparan sulfate) via highly
    cationic surface on C-type lectin-like fold. This interaction is central to MBP&#39;s
    biological activities - enables binding to pathogen surfaces, host cell membranes,
    and tissue matrix components.
  locations:
  - id: GO:0005576
    label: extracellular region
  - id: GO:0030133
    label: transport vesicle
  directly_involved_in:
  - id: GO:0002215
    label: defense response to nematode
  - id: GO:0042742
    label: defense response to bacterium
  supported_by:
  - reference_id: file:human/PRG2/PRG2-uniprot.txt
    supporting_text: Crystal structure reveals heparin-binding site; MBP damages helminth
      and bacterial membranes via cationic interactions.
proposed_new_terms:
- proposed_name: cytotoxic effector activity
  proposed_definition: The activity of directly killing or damaging target cells or
    organisms through membrane permeabilization or disruption, particularly via cationic
    charge-based interactions, as exhibited by antimicrobial peptides and granule
    proteins.
  justification: MBP&#39;s primary function is direct killing of parasites and microbes
    via membrane permeabilization. Current GO lacks specific term for this cationic
    antimicrobial peptide-like activity. Knockout mice show impaired parasite killing;
    purified MBP kills helminths, bacteria, fungi, and mammalian cells via membrane
    disruption.
  proposed_parent:
    id: GO:0003674
    label: molecular_function
- proposed_name: M2 muscarinic acetylcholine receptor antagonist activity
  proposed_definition: The activity of binding to M2 muscarinic acetylcholine receptors
    and blocking their inhibitory function, thereby preventing feedback inhibition
    of acetylcholine release from parasympathetic neurons.
  justification: MBP&#39;s allosteric antagonism of M2 receptors on airway nerves is a
    key mechanism in asthma pathophysiology, but lacks specific GO annotation. MBP
    binds M2 receptors, blocks inhibitory feedback, causes unrestrained acetylcholine
    release and bronchospasm. Heparin neutralization of MBP prevents this effect.
  proposed_parent:
    id: GO:0030594
    label: neurotransmitter receptor activity
status: DRAFT
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>